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Abstract
Unique Biological Applications of Charge Transfer Dissociation Mass Spectrometry
Halle M. Edwards
The ever-changing landscape of mass spectrometry is driven by gaps in knowledge, and
one of the biggest driving forces is the desire to understand the structure and dynamics of
biomolecules in living organisms. New and better methods of tandem mass spectrometry are often
at the heart of technological developments. Some fragmentation methods are limited to expensive
FTICR instruments, some techniques are limited multiply charged precursors, and others are
limited to breaking only the weakest bonds in precursor ions; all of which support the pursuit of
new activation methods. Charge transfer dissociation (CTD) addresses some of these concerns by
providing structurally informative fragmentation of singly or multiply charged precursors using a
benchtop instrument. Since its development, CTD has been successfully applied to several classes
of molecules including peptides, lipids, and oligosaccharides. This work builds on those
foundations to address three areas of potential interest: 1) the characterization of macrocyclic
structures like antibacterial macrolides, 2) the differentiation of leucine and isoleucine residues in
peptides, and 3) the discrimination of amino acid epimers and isomers, like D- and L forms of
aspartic acid and isoaspartic acid in different peptides.
For macrocyclic structures, we applied CTD to a variety of natural and synthetic
macrocycles, including cobalamins (e.g., Vitamin B12), macrolides (e.g., Erythromycin) and a
synthetic polymer (e.g., cyclic Nylon-6,6). For vitamin B12, CTD generated rich spectra that
contained a variety of cleavages around the nucleotide loop but not within the corrin ring of vitamin
B12. CTD of vitamin B12 also provided several neutral losses that corresponded to the axial ligand
plus either the central cobalt or an acetamide neutral, which have the same nominal mass. The
resolution of the 3D ion trap was insufficient to resolve the elementally distinct product ions, so
some peak assignments are currently ambiguous. For Erythromycin, we again observed more
numerous fragments with CTD than with CID, the latter of which was dominated by successive
losses of water. Additionally, the fragments obtained with CTD were more structurally informative
and indicative of the radical fragmentation produced in high energy techniques like EID and XUVDPI by others. CTD of singly protonated Nylon-6,6 produced an abundant CTnoD oxidation peak
with a charge of 2+, but no fragments. CID of the isolated 2+ radical at the MS3 level provided a

rich spectrum with excellent coverage of the polymer sequence. In contrast, CID generated only
successive monomer losses and water losses.
For leucine and isoleucine differentiation, model peptides and wild-type peptides
containing leucine or isoleucine were fragmented in their 1+ and 2+ charge states with CTD. The
results are compared to CID. The four model peptides of RGGGGXXGGGGR, where X is either
Leu or Ile, were indistinguishable with CID, but CTD distinguished the four isomers by providing
diagnostic side chain cleavages of the type d- and w ions. These d- and w ions were also apparent
in CTD fragmentation of the wild-type peptides, which enabled the correct identification of the
Leu and Ile residues in the wild-type peptides.
For the determination of amino acid epimers using CTD, experiments focused on
differentiating four isomers of aspartic acid—L-Asp, L-isoAsp, D-Asp, and D-isoAsp—within
linear peptides. Wild-type peptides, including the 1+ and 2+ charge states of FVIFLDVK,
GYQYLLEPGDFR, and HFSPEDLTVK, were also subjected to CTD, and the results were
compared with CID of the same precursors. CTD produced characteristic fragment ions at c+57
for isoAsp residues, but not for Asp residues. Thus, the two isomers can be readily distinguished
based on these fragments. These results are supported by the observations of others using electron
capture dissociation (ECD) and electron transfer dissociation (ETD). Additionally, the relative
intensities of z ions are found to be useful in identifying isoAsp residues. For epimers of Asp, CTD
delivers a degree of chiral differentiation similar to or greater than radical directed dissociation
(RDD), and a characteristic ion with the identity bn-45 Da or an-NH3 ion can be used to aid in the
identification of D-epimers of Asp and isoAsp. For example, R values of 41.0 and 37.5 were
produced with CTD of HFSPEDiLTVK at the 1+ and 2+ charge state, respectively. For CID of the
same peptide, the R values were only 7.9 for the 1+ charge state and 2.8 for the 2+ charge state.
In summary, CTD provides structurally informative fragmentation of biomolecules that is
quite similar to other high-energy fragmentation techniques like ECD, HECD, RDD, and XUVDPI. CTD has the added benefit of being implemented on a benchtop instrument, allowing for
greater accessibility. Furthermore, CTD can be applied to low charge state precursors, which
permits its application in studies of singly charged molecules that are unreachable with electronbased fragmentation methods. These advantages afforded to CTD position it to be an invaluable
tool in the study of biomolecules.
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1

Introduction
From its beginnings as a tool for studying atoms and isotopes, mass spectrometry has come a

long way in its ~100 year history.1,2 Weaving through history, mass spectrometry has played an
important role in many different disciplines, from determining atomic weights and analyzing
petroleum products to diagnostic medicine and proteomics.1,2 Among the many disciplines to
benefit from MS, biology has seen some of the greatest benefits from mass spectrometry’s
capabilities for characterization and quantitation. Biological systems are comprised of a wide array
of complex molecules, like proteins, metabolites, carbohydrates and nucleic acids, and their wide
range of concentrations in biological systems makes them difficult to detect and characterize.
Understanding the structure of these biomolecules is essential to understanding their functions and
relationships to health and diseases. Identifying and quantifying biomolecules can also be an
important factor in drug discovery and drug development.
The development of tandem mass spectrometry (MS/MS) and soft ionization techniques
helped position mass spectrometry to become a critical tool for structural studies of large
biomolecules3,4 As the applications for MS/MS broadened, so too did the technology, as new mass
analyzers and novel fragmentation methods entered the landscape. Today, tandem mass
spectrometry is an integral part of molecular structure analysis within a wide variety of disciplines,
including forensic analysis, proteomics, metabolomics, and drug discovery.
For biomolecular structure analysis, MS/MS is one of the most useful tools for determining
sequence information of peptides and proteins.2,5,6 In the classical “bottom-up” approach, proteins
are digested into short lengths of amino acids, or peptides.7 These peptides are then analyzed by
MS/MS to determine the sequence of amino acids within the peptide. Peptide fragmentation is

1

generally well understood and potential backbone fragments are organized by a simple
alphabetical nomenclature scheme (Figure 1.1).8,9
Techniques like CID and high-energy CID (HCD) are the most commonly used methods
for sequencing peptides because they are widely available and readily implemented on a wide
variety of platforms. CID is also efficient and generally applicable to most types of precursor ions.
In CID, inelastic collisions between ions and neutral gas molecules cause the conversion of kinetic
energy to internal energy in the precursor analyte. If enough energy is imparted in a single
collision, or if the collision frequency is fast enough, the internal energy of the precursor can
exceed its threshold for activation, and the ion can fragment into product ions. The
thermodynamics and kinetics of unimolecular fragmentations have been extensively described by
RRKM and quasi-equillibrium theory (QET) in the 1920s through 1950s.10–12
Fragmentation with CID typically results in cleavage of the weakest bonds in a molecule.
For peptides, CID therefore results in cleavage of the amide bond between amino acids, which
results in b- and y ions. At higher collision energies, a ions become more common. However, the
preference for lower energy dissociation pathways also results in the loss of labile post
translational modifications (PTMs), like phosphate-,13,14 sulfate-15 and nitrate16,17 groups, and
favors structurally uninformative neutral losses such as ammonia, water and CO 2.18,19 Whereas
CID is generally sufficient to determine the sequence of many peptides, CID fails to distinguish
between isomeric amino acids and often fails to pinpoint labile PTMs. Further, rearrangement of
PTMs—and phosphate groups in particular—to other residues is rather common with CID, which
leads to the erroneous assignment of PTMs along the peptide backbone.14 In these cases, higher
energy dissociation methods are needed to fully elucidate the structure of a peptide. Radical-driven
fragmentation techniques, such as those induced by electrons20–23 and UV photons,24,25 tend to
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generate c/z- and a/x fragments. At the highest collision energies, or for alternative higher energy
fragmentation techniques, fragmentation is also observed along the side chains of amino acids,
which leads to the formation of d-, w-, and v ions.26 Whereas CID remains the method of choice
for sequencing peptides, many complementary dissociation methods have emerged and gained a
foothold in proteomics.

Figure 1.1 Peptide fragment nomenclature scheme showing backbone cleavages and secondary ions
formed from side chain losses.

1.1
1.1.1

Higher Energy Fragmentation
ECD and ETD
Electron capture dissociation (ECD) was introduced in 199827 as an alternative dissociation

technique to complement other “slow heating” fragmentation methods like CID and infrared
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multiphoton dissociation (IRMPD).28 In contrast to CID and IRMPD, which form product ions
through the lowest energy pathways and cleave the weakest bonds, ECD follows a less ergodic
mechanism that cleaves bonds before energy is redistributed throughout the molecule.27,29 ECD
involves the interaction of multiply charged precursor ions with low-energy electrons (<0.2 eV).
During these interactions the precursor captures an electron and creates a charge-reduced radical
species ([M+nH](n-1)+•) that then readily dissociates into fragments (Equation 1).27 Activation of a
multiply charged ion by ECD typically results in the formation of c- and z ions for peptides, which
are complementary to the b- and y ions produced with CID.20 In addition to the c/z backbone
cleavages, ECD demonstrates an ability to preserve labile PTMs that are often lost with CID. 30,31
Likewise, the negative mode counterpart of ECD, electron detachment dissociation (EDD), also
preserves PTMs and generates ions through radical-directed pathways, which produce both c/zand a/x ions.32,33

•

[𝑴 + 𝒏𝑯]𝒏+ + 𝒆− → [[𝑴 + 𝒏𝑯](𝒏−𝟏)+ ] → 𝒇𝒓𝒂𝒈𝒎𝒆𝒏𝒕𝒔

Equation 1.1

Interactions between precursor ions and higher energy electrons (e.g., 10 eV) is termed hot
ECD (HECD), and HECD can result in extensive secondary fragmentation in the form of side
chain losses.34 These secondary fragments, termed d-, w-, and v ions can be used to differentiate
some isomeric amino acids like leucine and isoleucine. 35–37 The differing side chain structures of
leucine and isoleucine give rise to the formation of unique secondary ions. For leucine, HECD
produces a characteristic loss of 43 Da from the z• ion, which corresponds to the loss of •CH(CH3)2
from the leucine side chain. In contrast, HECD produces a characteristic loss of 29 Da from the
same z• ion for isoleucine, which corresponds to the loss of •CH2CH3. These w ions are a reliable
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way to distinguish between leucine and isoleucine. Theoretically, d ions can also be formed by the
same neutral losses of 43 Da and 29 Da from an adjacent a• ion, but d ions are rarely observed in
HECD spectra.35 Secondary ions of the type d-, w- and v can extend beyond distinguishing Leu/Ile
to other isomeric amino acids, as well.38,39
Although ECD has established itself as an essential tool for proteomics, ECD has some
major limitations. First, the capture of an electron by the precursor necessitates that the precursor
be multiply charged; capture of an electron by a singly charged species would result in a neutral
and would not be observable. Although ESI often generates multiply charged species, acidic,
neutral and smaller molecules tend not to form multiply protonated precursors, and often only form
singly charged precursors. Second, ECD is generally restricted to expensive Fourier transform ion
cyclotron resonance (FTICR) instruments, which limits the availability to only the wealthiest of
laboratories. Finally, the presence of radical traps, such as nitrate groups, on the peptide hampers
backbone cleavages, limiting the amount of sequence coverage that could be obtained.40–42
The limited access to FTICR mass spectrometers led Hunt’s group to develop electron
transfer dissociation (ETD) in 2004.23 Like ECD, ETD involves the capture of an electron by
multiply positively charged precursor ions. In contrast to ECD, ETD uses aromatic, radical anions
as a source of electrons instead of free electrons. Because of their increased mass relative to
electrons, radical anions, typically generated from anthracene23 or fluoranthene,43 can be co-stored
in an ion trap alongside precursor ions, thus eliminating the need for an FTICR. ETD generates cand z ions for peptides, which form via cleavage of the N-C bond and preserves labile PTMs,
both of which make ETD an attractive choice for peptide sequencing.44
Negative electron transfer dissociation (NETD) is the complement of ETD. 45,46 In NETD,
positive ions like Xe and other noble-gas cations45 are used to abstract an electron from multiply
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negatively charged precursor ions. The electron transfer from the precursor ion to the reagent
cation results in charge reduction of the precursor ion and a radical site, which gives
complementary a- and x ions for peptide anions, in addition to some distinctive side chain
losses.21,47–49
The efficiency of ETD depends on the charge state of the precursor ion. The Landau-Zener
effect dictates that higher charge states have reaction rates that increase relative to the square of
the charge states of the oppositely charged reagents, so multiply charged ions have significantly
greater rates of reaction, and ETD efficiencies, relative to lower charge states. 50 Precursors with
charge states of 3 or less tend to provide charge-reduced species without fragmentation (ETnoD),51
but larger molecules that can accommodate multiple charges are more successful. To overcome
this limitation, supplemental activation can be applied in the form of collisional activation or
infrared radiation to these charge-reduced species to produce informative fragments, termed
activated ion ECD/ETD (AI-ECD/ETD).52–54

1.1.2

UVPD
In addition to the electron-based fragmentation techniques described above, high-energy

photoactivation can be applied to peptides of any charge state. The photon energies in such
experiments are either in the ultraviolet (UV) or extreme ultraviolet (XUV), typically between
157-193 nm55,56 and 40-80 nm57 range, respectively. In ultraviolet photodissociation (UVPD),
absorption of a photon by the precursor leads to electronic excitation, but not ionization, of certain
bound electrons (equation 2). UVPD is an appealing choice for peptide sequencing due to its
potential to form a/x-, b/y- and c/z ions of peptides.56,55,58–60 However, UVPD requires the
precursor to contain a specific chromophore that is suitable for absorbing the wavelength of the
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activating photons. In peptides, the amide bond functions as the chromophore. Amide bonds have
absorption maxima at 190 nm and 160 nm,61 which makes Nd-YAG harmonics at 157 nm and 193
nm well-suited to fragment peptides. Another benefit of UVPD is that photoabsorption is quite
independent of polarity, so UVPD can be performed in either positive or negative mode. UVPD
of peptide anions tends to produce more dominant a- and x ions than peptide cations.24,56,62

[𝑴 + 𝒏𝑯]𝒏+ + 𝒉𝒗 → [[𝑴 + 𝒏𝑯]𝒏+ ]∗ → 𝒇𝒓𝒂𝒈𝒎𝒆𝒏𝒕𝒔

Equation 1.2

Adding to its appealing nature, photodissociation can be implemented on a wide variety of
instruments, including ion traps,63,64 TOF instruments65–67 and hybrid Orbitrap instruments.68
UVPD is commercially available on the Orbitrap platform through Thermo Scientific, though the
cost of this particular platform may also be prohibitively expensive for many labs.
The need for a chromophore is a mild drawback for UVPD, especially when precursor ions
do not contain an inherent chromophore at the wavelength of the pulsed laser. Chemical
modification can be used to add a chromophore to the analytes, but modification procedures create
additional problems and add to the overall analysis time.69,70
1.2

Emerging Techniques
In addition to more established methods of ECD, ETD and UVPD, other dissociation

techniques have emerged that demonstrate promise for characterization of peptides and other
biomolecules.
1.2.1

RDD
Analogous to UVPD, activation by 266 nm photons can allow for site-selective radical

generation, as demonstrated in radical-directed dissociation (RDD).71 Insertion of a carbon-iodine
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bond into a peptide and subsequent irradiation by 266 nm photons specifically cleaves the C-I
bond, leaving a radical at the cleavage site.72 Isolation and collisional activation of this radical
species leads to extensive fragmentation of the peptide, often generating unique spectra between
epimers of amino acids (Figure 1.2).73 As such, RDD has become one of the preferred dissociation
methods for distinguishing between D- and L epimers of amino acids like aspartic acid and
glutamic acid.73–75 RDD also works in the top-down analysis of proteins.76 However, RDD always
requires a specific chromophore, like an iodination tyrosine residue, which may limit its
applicability in certain situations.

A

B

Figure 1.2 Fragmentation spectra for peptide DVGSNK containing either L-serine or D-serine in position
four. a) CID spectra show little difference between L- and D epimers. b) RDD shows the major differences
observed in the losses of water and NH3 for L- and D epimers of serine. Adapted with permission from Tao,
et. al.73Copyright 2012 American Chemical Society.

1.2.2

XUV-DPI
Extreme-ultraviolet dissociative photoionization (XUV-DPI) is another, more recent,

photo activation technique that delivers far more informative fragments of molecules than can be
achieved with CID.77,78 XUV-DPI uses photons in the range of 10-100 nm (12.4 eV – 124 eV).
These energies far exceed the ionization threshold of molecules.57 Different from UVPD, in which
dissociation proceeds from electronic excited states of ions, XUV-DPI involves photoionization.
The loss of an electron from the even-electron precursor creates a radical site on the oxidized ion
and results in radically-driven fragmentation pathways (equation 3).79,80 For the characterization
8

of complex oligosaccharides, XUV-DPI provides full sequence coverage that can distinguish
between isomeric species and pinpoint labile modifications. 78 For peptides, XUV-DPI produces
a/x-, b/y-, and v ions, similar to UVPD.79 Until recently, XUV-DPI has been restricted to
synchrotron facilities, which are required to generate XUV photons with sufficient intensity to
conduct the experiments. Access to beam facilities was therefore a severe limitation to progress
and widespread adoption. Recent proof-of-concept experiments showed that XUV photons can be
generated through gas discharge photon sources, making it possible to implement XUV-DPI in a
laboratory setting.79 However, this “benchtop XUV-DPI” method is inefficient and still in the early
stages of development.

[𝑴 + 𝒏𝑯]𝒏+ + 𝒉𝒗 → [[𝑴 + 𝒏𝑯]𝒏+ ]• + 𝒆− → 𝒇𝒓𝒂𝒈𝒎𝒆𝒏𝒕𝒔

1.2.3

Equation 1.3

Metastable atom-activated dissociation
Another radical-driven fragmentation technique is metastable atom activated dissociation

(MAD), which was discovered by Zubarev’s group81 and developed by the Jackson group.82–87 In
MAD, isolated precursor ions of any charge state except 1 - are exposed to a beam of metastable
atoms or a rare gas, like helium. Penning ionization of the precursor ions generates radical species
with excess energy, which causes them to fragment with energies and pathways that resemble
XUV-DPI. For example, fragmentation of peptides with MAD results in backbone cleavages of
all types (a/x, b/y, c/z), including d ions, which help differentiate leucine from isoleucine residues,
as described above.87 Additionally, MAD preserves labile PTMs like phosphorylation, 82,85
sulfonation,82 and nitration.86
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1.2.4

Charge transfer dissociation
Work by Zubarev and Schlathölter initially investigated the use of a beam of high-energy

cations as a means of activation for peptides.88–90 As shown in figure 1.3, air-plasma activation of
angiotensin resulted in a variety of backbone cleavages similar to CID (b/y/a ions) and ECD/ETD
(c/z ions), which suggests this method of activation is able to access higher-energy dissociation
pathways, as well as lower vibrational excitation pathways.88 In complement, Schlathölter’s work
with keV H+-, He+-, and He2+ cations resulted in all types of backbone cleavages and abundant
amino acid side chain losses of leucine enkephalin.89,90 Building on this approach to ion activation,
the Jackson group has made significant progress in developing a related technique, charge transfer
dissociation (CTD), for the analysis of biomolecules.

Figure 1.3 Fragmentation of angiotensin with a) air-plasma cations produces backbone cleavages similar
to b) ETD and c) HCD. Reprinted with permission from Chingin, et. al.88 Copyright 2014 American
Chemical Society.
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Charge transfer dissociation (CTD), uses a beam of high-energy He cations for ion
activation, though recent work91 shows alternative gases like hydrogen, nitrogen, and lab air can
be used interchangeably with He. Initial work with CTD of singly charged peptide cations showed
a variety of backbone cleavages (a/x-, b/y-, and c/z ions) are produced, as well as abundant a+1
ions indicative of radical driven fragmentation common to UVPD. 92,93 Additionally, amino acid
side chain losses are observed with CTD of substance P and bradykinin.93 For larger proteins, CTD
along with CID activation at the MS3 level can break disulfide bonds of insulin, providing a greater
number and more informative fragments than can be obtained with either CTD or CID alone.94 In
addition to peptides, CTD has shown great capacity for providing informative fragmentation of
complex oligosaccharides95–102 and lipids.103 For oligosaccharides, CTD provides cross ring
cleavages which allow for complete sequencing,95 pinpointing of labile modifications,96,98 and
linkage determination.97,101,102 Further, CTD is compatible with online separations, allowing for
isomer differentiation of complex mixtures of oligosaccharides.99,100
Whereas structural characterization of peptides and other biomolecules can be
accomplished through many different routes and fragmentation techniques, there remain some
challenges that have yet to be fully addressed. Those limitations generally fall into some discrete
categories: 1) the need for expensive or inaccessible instruments or resources, 2) the need for high
charge state precursors, and 3) the need to chemically modify the native structure through covalent
modification of a chromophore. This dissertation focusses on the use of CTD, which attempts to
overcome the limitations of other techniques.
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Table 1.1 Comparison of fragmentation methods and their applications to peptides
Fragmentation Method

Precursor Ion Charge

Application to Peptides

CID

+/-

Produces b/y/a ions

ECD

2+

Produces c/z ions
Preserves PTMs

HECD

2+

Produces c/z ions
Side chain cleavages (w ions)

EDD

-

Produces c/z- and a/x ions
Preserves PTMs

ETD

2+

Produces c/z ions
Preserves PTMs

NETD

2-

Produces a/x ions
Side chain losses

UVPD

+/-

Produces a/x-, b/y-, and c/z ions

RDD

+

Epimer differentiation

XUV-DPI

+/-

Produces a/x-, b/y-, and v ions

MAD

+/-

Produces a/x-, b/y-, c/z ions
Side chain cleavages (d ions)

CTD

+/-

Produces a/x-, b/y-, c/z ions
Side chain cleavages (d/w/v ions)
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2

Structural Characterization of Natural and Synthetic Macrocycles Using
Charge Transfer Dissociation Mass Spectrometry (CTD-MS)

2.1

Introduction
The need to create new therapeutics to treat infectious diseases has created a resurgence of

research into natural products (NPs).104 Prior to the development of modern synthetic drugs, people
turned to plants and nature to remedy their ailments. Natural products are any compound produced
from a living organism, but most pharmacologically active compounds tend to be metabolic
products that plants and fungi use to protect themselves from predation. 105,106 Some famous
examples of drugs derived from NPs include aspirin, which has its origins in willow tree bark, 107
and opioids like morphine, which are derived from the poppy plant.108 Even as drug development
grew out of the textile and dye industries in the second half of the 20 th century, most synthetic
drugs were derived from, or inspired by, a natural compound.109,110
Many NPs have complex structures—including cyclic-, polycyclic- or macrocyclic rings—
which can make them difficult to both characterize and synthesize. One example of the potential
structural complexity can be found with vitamin B12 (Figure 2.1), a critical coenzyme for many
bodily functions in animals. The structure of vitamin B12 was outlined in 1956111 but was not fully
synthesized until nearly 20 years later by Woodward’s group. 112 Vitamin B12 has been
demonstrated to be a promising drug delivery tool when certain active sites on the molecule are
modified, so the ability to obtain comprehensive MS/MS characterization of vitamin B12 could
facilitate it’s development as a novel drug or drug-delivery tool.113 The structural characterization
of compounds like vitamin B12 is also important in cancer research, where rapidly growing cancer
cells have an increased demand for essential vitamins like vitamin B 12. Delivering modified
versions of vitamin B12 can target and disrupt the replication of cancer cells,114 and the exaggerated
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uptake of vitamin B12 by cancer cells can be useful in imaging applications that dose patients with
fluorophore-modified versions of vitamin B12.115
Vitamin B12 contains a polycyclic porphyrin ring, a cyclic sugar, a cyclic benzimidazole
region and a macrocyclic structure when the benzimidazole ligand bonds to cobalt in the core of
the porphyrin ring (Figure 2.1). These ring structures tend to limit the extent of structural
information obtained by collision-induced dissociation (CID), especially because of the presence
of labile bonds and leaving groups, like the phosphate group and the monodentate cobalt ligand. 116–
120

Figure 2.1 Basic structure of vitamin B12 or cobalamin. The R represents one of three substituents for the
most common forms of vitamin B12: -OH for hydroxocobalamin, -CN for cyanocobalamin and -CH3 for
methylcobalamin. Major structural components indicated. DMB represents 5,6-dimethylbenzimidazole.

Polycyclic and macrocyclic NPs are very common in nature. Erythromycin is a widely used
antibiotic that is derived from the soil bacteria Saccharopolyspora erythraea. Erythromycin
14

contains a characteristic macrocyclic ring known as a macrolide. 121,122 Since it’s development in
1952, Erythromycin has been modified in a variety of ways to create several NPs with different
uses and activities.123–134 These variants are commonly referred to as Erythromycins A through D.
When Erythromycin is characterized using commonly available mass spectrometric techniques
like CID, the tandem mass spectra are dominated by successive water losses that provide very little
structural information.135,136 Other higher-energy techniques, like EID137 and XUV-DPI,79 provide
more extensive fragmentation of erythromycins, richer spectra, and significantly more structural
information than CID.
Cyclic synthetic polymers have been investigated as important drug delivery tools, because
they often have a greater drug loading capacity than other molecules and they can help deliver
drugs that have poor solubility on their own.138,139 Drugs paired with cyclic polymers can offer a
longer circulation time in the blood and provide a more controlled release with longer
efficacy.138,139 However, the fragmentation of cyclic polymers results in successive losses of
monomers, which reveals little about the structure of the monomers.140,141
The ability to observe fragment ions from macrocycles relies on the ability to cleave multiple
covalent bonds following each activation. Towards this end, CTD has demonstrated the ability to
break two covalent bonds in single activation events in several cases: 1) to form cross-ring
fragments of hexose rings in oligosaccharides,95–102 2) to form backbone cleavages of proteins
within disulfide-linked proteins,94 and 3) to form d- and w ions of peptides.92,93 In this paper, we
investigate the ability of CTD to provide fragmentation of three different types of challenging
macrocycles.
First, we studied vitamin B12, which features a central corrin ring along with two axial
ligands coordinated to a central cobalt ion.111,142 Second, we investigated the fragmentation of
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different macrolide antibiotics: Erythromycin A, B, and C. Finally, we investigated the
fragmentation behavior of an interferent in the analysis of a glycan experiment, which was
identified as a cyclic polymer of Nylon-6,6. Whereas nylon is not an NP, it is a common
contaminant in MS/MS and LC-MS experiments, and its amide linkages bear structural similarity
to many natural prodcuts.143,144 Detailed characterization of these important classes of macrocycles
can have far reaching impacts in drug discovery, development, and delivery. The results indicate
that CTD on a bench-top ion trap mass spectrometer produces significantly more structurally
informative fragments than can be accomplished using conventional tandem mass spectrometry
approaches like CID.
2.2
2.2.1

Methods
Instrumentation
CTD and CID experiments were performed on a modified Bruker amaZon 3D ion trap

mass spectrometer (Bruker Daltonics, Bremen, Germany). To perform CTD, a saddle field fast ion
source interfaced with the vacuum cover lid was mounted directly above a 3-mm hole in the ring
electrode of the ion trap. A pulsed high voltage to the anode of the ion gun is timed to permit ~6
keV helium ions into the trap for periods ranging from 20-100 ms. Full instrument modifications
are described elsewhere.83,92,93 UHP helium from Matheson TRIGAS (Fairmont, WV) was used as
the reagent gas for all experiments, although recent work has shown that the nature and purity of
the reagent gas might not be important.91
2.2.2

Samples
Vitamin B12 (cyanocobalamin and methylcobalamin) were purchased from Sigma Aldrich

(St. Louis, MO, USA). Erythromycin A was purchased from Acros Organics (Palo Alto, CA,
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USA), and Erythromycin B and C are European Pharmacopoeia reference standards from the
European Directorate for the Quality of Medicines (Strasbourg, France). All solutions were
prepared in a water/methanol/formic acid mixture (49.5:49.5:1 v/v/v) with a final concentration of
100 ppm. HPLC grade methanol and formic acid (Fisher Scientific, Fair Lawn, NJ, USA) were
used for sample preparation.
2.2.3

Experimental
Vitamin B12 solutions were introduced to the MS inlet with an electronic syringe pump at a

flow rate of 5.0 L/min and a voltage of 3.5 kV. Erythromycin samples were ionized by a static
nanospray source at a voltage of 1500 V. The low mass cutoff (LMCO) was set to 250 and an
isolation width of 4 Da was used for all experiments. CID experiments were performed with a
reaction amplitude of 0.5-1.5 V. For CTD experiments, fragmentation was achieved by exposing
precursor ions to 5-7 keV helium cations pulsed for 100 ms. A leak valve maintained the flow of
helium into the vacuum chamber at 1.2x10-5 mbar. To prevent unwanted space charge effects, any
unreacted precursor ions remaining after CTD were resonantly ejected with a CID amplitude of
1.0-7.0 V before mass acquisition.
For experiments with Nylon-6,6, the singly charged precursor at m/z 453.3 was isolated then
fragmented by CTD. The doubly charged product ion at m/z 226.5 was then isolated and
fragmented by CID at the MS3 level. The LMCO was set to m/z 50, and the CID amplitude was
0.8 V.
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2.3

Results & Discussion

2.3.1

Vitamin B12
CID of Vitamin B12 produced relatively few product ions and is restricted to masses above

m/z 900 (Figure 2.2a). Most of the product ions in the CID spectra arise from neutral losses of the
major structural components, including the 5,6-dimethylbenzimidazole base (DMB, C9H10N2,
146.08 Da), the combined loss of 5,6-dimethylbenzimidazole base and deoxy ribose sugar
(DMB+DR, C14H16O3N2, 261.12 Da) and the nucleotide loop (NL, C14H17N2O6P, 340.08 Da).
Peaks corresponding to one or more neutral water losses from these fragments are also observed
(Figures 2.2a and 2.3a).

1,377.50 [M + Na]+

1,328.38 [M+H - HCN]

1355.57 [M+H]+ �
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1,124.38 [M+H - DMB, ▲]

1,154.38 [M+H - DMB+CHO, HCN]

1,095.38 [M+H - DMB+DR]

1,049.38 [M+H - DMB+DR, H 2O, HCN]
1,067.38 [M+H - DMB+DR, HCN]

1,077.38 [M+H - DMB+DR, H2O]

969.38 [M+H - NL, H2O, HCN]
987.38 [M+H - NL, HCN]
992.38 [M+H - DMB+DR, H2O, ▲]
997.38 [M+H - NL, H2O]
1,010.25 [M+H -DMB+DR, ▲]
1,015.38 [M+H - NL]

943.38 [M+H - NL +C3H6NO]

912.38 [M+H - NL, H2O, ▲]

930.38 [M+H - NL, ▲]

884.38 [M+H - axial ligand]

2000

839.25 [M+H - axial ligand, HCONH2]

4000

825.25 [M+H - axial ligand, CH3 CONH2]

6000

635.13 [M+H -▲]2+•

455.50 [M+H - NL, H2O, ▲]2+'

358.88 [NL+H2O]+

8000

340.88 [NL]+

Intensity

10000

485.13 [M+H - NL, H2O, HCN]2+•

CTD
12000

858.38 [M+H - axial ligand, HCN]

664.25 [M+H - HCN]2+•

1355.57

14000

677.75 [M+H]2+•

b

800.25 [M+H - axial ligand, ▲]

a

0
290

390

490

590

690

790

890

990

1090

1190

1290

1390

m/z

Figure 2.2 CID spectrum of cyanocobalamin, and b) CTD spectrum of cyanocobalamin. ▲ represents a
loss of either CoCN (84.94 Da) or ●CN and CH3CONH2 (85.04 Da). Abbreviations are as follows: DMB =
5,6-dimethylbenzimidazole base (C9H10N2, 146.08 Da); DMB+DR = 5,6-dimethylbenzimidazole base and
deoxy ribose sugar (C14H16O3N2, 261.12 Da); NL = nucleotide loop (C14H17N2O6P, 340.08 Da).
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Figure 2.3 a) CID spectrum of methylcobalamin, and b) CTD spectrum of methylcobalamin. ◼️ represents
a loss of either CoCH3 (73.96 Da) or ●CH3 and CH3CONH2 (74.06 Da). Abbreviations are as follows: DMB
= 5,6-dimethylbenzimidazole base (C9H10N2, 146.08 Da); DMB+DR = 5,6-dimethylbenzimidazole base
and deoxy ribose sugar (C14H16O3N2, 261.12 Da); NL = nucleotide loop (C14H17N2O6P, 340.08 Da).

When comparing CID and CTD of protonated vitamin B12, CTD produces many more
fragments across a wider range of m/z values. Most of the product ions from CTD derive from
cleavages within the nucleotide loop. CID also breaks bonds in this region, but not to the same
extent. In addition to cleavages within the nucleotide loop, CTD and CID also induce the loss of
water and other small molecules from many of the product ions. For example, with
cyanocobalamin (CNCbl), the CTD spectrum produces several product ions that include neutral
losses of HCN, which must involve a rearrangement of hydrogen atom to the cyanide group bonded
to the central cobalt ion (Figure 2.4). In contrast, CID of cyanocobalamin does not produce any
analogous losses of HCN. Likewise, with methylcobalamin (MeCbl), which has a methyl group
coordinated to the central cobalt, the CTD spectrum contains many instances of methyl radical loss
(Figure 2.5), but the CID spectrum does not.
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Unique to the CTD spectra of CNCbl and MeCbl are losses of 85 Da and 74 Da. These
losses are most likely the loss of the central cobalt along with the axial ligand (-CoCN, 84.94 Da;
-CoCH3, 73.96 Da). However, the limited mass resolution prevents confident assignment of these
neutral losses because the peaks are nominally isobaric with the loss of the axial ligand plus one
of the acetamide groups along the perimeter of the corrin ring (●CN and CH3CONH2 = 85.04 Da;
●CH

3

and CH3CONH2 = 74.06 Da). The extensive fragmentation along the various parts of the

macrocyclic region suggests that any modifications along the macrocycle would be more readily
identified using CTD than CID. The richness of the CTD spectrum is consistent with the ability to
break two or more covalent bonds in a single activation event, and with the ability to provide
access to higher energy, radical-driven pathways that cause fragmentation away from the charge
site and the most labile bonds.
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Figure 2.4 CTD fragmentation diagram of cyanocobalamin ▲ represents a loss of either CoCN (84.94
Da) or ●CN and CH3CONH2 (85.04 Da).
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Figure 2.5 CTD fragmentation diagram of methylcobalamin. ◼️ represents a loss of either CoCH3 (73.96
Da) or ●CH3 and CH3CONH2 (74.06 Da).

2.3.2

Erythromycin
Erythromycins A, B and C (EA, EB, EC) differ in the presence of hydroxy or methoxy

substitutions at two different locations on the macrocycle. One site of substitution is on the C3
position of the cladinose ring, and the other is in the C12 position of the macrocyclic ring.
Collision-induced dissociation of EA, EB and EC results in spectra (Figure 2.6a-c) that are
dominated by the loss of the cladinose and/or mycarose groups from the macrocycle and fragments
corresponding to successive water losses thereof. The spectra contain minimal structural
information about the macrolide itself. The neutral loss differences between the three structures
indicate differences in the sugars attached to the macrocycle, but nothing can be inferred about the
structure of the sugars or their location in the macrolide. In these respects, our CID results are
qualitatively consistent with previous CID studies.135,136,145,146
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CTD of Erythromycin A, B, and C provided a greater number and greater diversity of
fragments than CID (Figure 2.7a-c). For each sample, we observed extensive fragmentation of the
macrocyclic ring, some of which are also accompanied by a cross-ring cleavage of one of the sugar
groups. The fragmentation patterns and the identified peaks are very similar to those produced in
previous work by others using EID or XUV-DPI with high mass accuracy detection.79,137 The
proposed fragments are outlined in Table 2.1 and the fragmentation nomenclature follows that
outlined by Wills, et. al.137 All three dissociation methods (EID, XUV-DPI and CTD) produce the
same cross-ring cleavage (BD) of the cladinose ring. This same cross-ring cleavage is produced
with CTD of precursors EB and EC, which makes the ion an important fragment for pinpointing
modifications to the attached sugar group. CTD also produces a cross ring cleavage of the
desosamine sugar for EA and EB. Specific cleavages of the macrocyclic ring—including
fragments IL, FG, and NP-H2O—are also observed with XUV-DPI, EID, and CTD. Many of the
neutral losses reported with EID are observed in the CTD spectra, particularly the neutral losses
following loss of the cladinose sugar (fragment E).
Macrolide analogs contain a variety of chemical modifications within the sugar groups and
along the macrocycle, and the ability to pinpoint and identify these modifications is critical to
distinguishing isomers and metabolites. Intra-sugar cross-ring cleavages can provide information
about modification positions within the sugar groups, whereas multiple cleavages along the
macrocycle can pinpoint and identify changes in the macrolide ring. Erythromycin A and C only
differ in the nature of the cladinose sugar, so any cleavages that involve the elimination of the
cladinose sugar should fall at the same mass. As an example, a neutral loss of the cladinose sugar
group (-158 Da for EA and -144 Da for EC) results in a peak at m/z 576.4 for both EA and EC,
which localizes any modifications to the lost sugar group rather than within the macrocycle.
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Erythromycin B differs from EA only in a single substituent on the macrocycle. The loss of the
cladinose sugar (-158 Da) from EB results in a peak at m/z 559.4, indicative of the structural
differences between EA and EB along the macrocyclic ring. Furthermore, several identified peaks
in the EB spectrum are observed to be 16 Da less than the same peaks within the EA spectra, which
helps identify the modification as an oxygen.
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Table 2.1 Common fragments of Erythromycin A among three different
dissociation methods
m/z
716.5

XUV-DPI79
O]+

[M+H-H2

O]+

[M+H-H2

CTD
[M+H-H2O]+

648.4

[M+H-C5H10O]+

[M+H-C5H10O]+

630.4

[M+H-C5H12O2]

[M+H-C5H12O2]+

602.4

BD

BD

BD

BD – H2O

BD – H2O

584.4

[M+H-C5H10O]+

576.4

E

E

E

575.4

E-H

E–H

E–H

574.4

E – H2

E – H2

560.3

E – CH4

E – CH4

558.4

E – H2 O

E – H2O

557.4

E – H2O -H

E – H2O -H

556.3

E – H2O -H2

E – H2O -H2

542.4

E – H2 O2

E – H2O2

540.4

E-2H2O

E – 2H2O

E – 2H2O

522.3

E-3H2O

E – 3H2O

E – 3H2O

514.3

F-C2H5O

F – C2H5O

490.3

HI

HI

489.3

JK

JK

477.3

G – C2H10O3

G – C2H10O3

JK – CH5

JK – CH5

HK – 3H2O

HK – 3H2O

472.3

JK-CH5

464.3

2.3.3

EID137

444.3

IL

IL

IL

411.2

NP-H2O

NP – H2O

NP – H2O

393.2

NP-2H2O

NP – 2H2O

NP – 2H2O

381.2

NP-CH4O2

NP – CH4O2

NP – CH4O2

365.2

FG

FG

FG

Nylon
While conducting CTD experiments of a laminarin sample97 we noted a consistent singly

charged peak was observed at m/z 453.3 in the full spectrum. The peak was accompanied by an
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[M+Na]+ peak at m/z 475.3 and an [M+K]+ peak at m/z 491.3, and all three peaks were determined
to derive from the use of a nylon membrane filter during sample preparation. To confirm the
identity of the substance, we subjected the protonated precursor at m/z 453.3 to CID and CTD.
Upon CTD fragmentation of the [M+H]+ precursor, very few fragments were produced other than
an intense [M+H]2+• ion at m/z 226.6. However, CID of the CTnoD product ion at m/z 226.6, at
the MS3 level, produced several product ions in the region m/z 70-453. Previous work has shown
that CID fragmentation of radicals generated from CTD or metastable atom activated dissociation
(MAD) can be a useful approach to obtaining richer spectra with superior S/N than CTD or MAD
alone.83,94 Based on the fragmentation pattern, the unknown peak was found to be a cyclic polymer
of Nylon-6,6, which is a reported contaminant commonly found in MS/MS and LC-MS
experiments.143,144
In hindsight, the intense CTnoD peak, [M+H]2+•, is caused by the cleavage of one covalent
bond in the macrocycle, which does not produce any neutral losses because the ‘fragments’ are
still covalently bound through the macrocycle structure (Scheme 2.1). However, additional
activation through CID at the MS3 level activated the radical species and resulted in the
information-rich spectrum in Figure 2.8b.

Scheme 2.1 Proposed pathway for the formation of the CTnoD product ion at m/z 226.6.
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One challenge in identifying the unknown contaminant was in determining if it was a cyclic
tetramer of Nylon-6 or a cyclic dimer of Nylon-6,6, because the two species are isobaric and both
have been identified as common contaminants in MS/MS experiments. A Nylon-6 monomer
contains 6 carbons and the repeat unit weighs 113.16 g/mol. 147 If the unknown species were a
Nylon-6 tetramer, then one would expect to see multiple losses of 113 Da in the CID spectra,
which correspond to successive monomer losses. However, such losses are not observed, so
Nylon-6 can be excluded. Nylon-6,6 has a repeat unit weighing 226.32 g/mol148 and a peak
corresponding to the loss of a Nylon-6,6 monomer is observed as a singly-charged product at m/z
226.2 in the CID spectrum. Comparison to previously reported MS/MS spectra of Nylon 6,6
confirmed the identity of this unknown contaminant to be a cyclic dimer of Nylon-6,6.143
The fragments produced from CID of the precursor at m/z 453.3 and CID of the CTnoD
product ion at m/z 226.6 are outlined in Figure 2.8a-c. The CID fragments are labeled according
to those outlined by Tran and Doucette.143 CTD-CID product ions are distributed throughout the
polymer chain and provide much greater coverage of the molecule. These numerous fragments
could provide clarification into individual monomer units and help pinpoint any modifications
along the polymer chain, had they been present.

29

a

453.5
CID

b

453.5
CTD
226.5
CID

Figure 2.8 a) CID fragmentation of [M+H]+ peak at m/z 453.3 and b) CTD-CID fragmentation of nylon
6 at m/z 226.6. c) Nomenclature follows that outlined by Polce149 with the addition of the  superscript to
designate -2H observed with CTD. Fragments in blue correspond to the first monomer unit, while fragments
in orange correspond to the second monomer unit.
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The hybrid CTD-CID technique could also be a useful tool for characterizing other difficultto-fragment cyclic polymers. Not only does CTD initiate ring opening, but CTD also generates a
radical species that generally produces more abundant and informative product ions than can be
obtained with traditional CID. In comparison to other high-energy techniques, CTD-CID may
outperform ECD of synthetic polymers, which has been reported to provide limited information
beyond that obtained by CID.20
2.4

Conclusion
CTD produces a greater distribution of fragment ions from macrocyclic structures than

conventional fragmentation approaches like CID. In cases where comparisons to EID and XUVDPI are possible, CTD spectra shows considerable similarities with the other high energy and
radical fragmentation approaches, with the benefit that CTD can be performed on an instrument
as simple as a bench-top ion trap. The enhanced fragmentation afforded by CTD allows for more
confident structural determinations, which can be vital to the biological functions and
modifications in biochemical systems. In addition, we have demonstrated CTD as a new method
to generate radical species from cyclic polymers, which allows for simpler and more informative
sequencing when subjected to CID at the MS3 level of fragmentation. Whereas CTD provides rich
and informative spectra, the mass resolution of the current instrument limits spectral interpretation
because of the isobaric nature of some of the product ions. The ability to perform CTD with high
resolution mass spectrometry would be helpful in elucidating some neutral losses and providing
greater confidence in the identity of the fragment ions.
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3

Differentiation of Leucine and Isoleucine Residues in Peptides Using
Charge Transfer Dissociation Mass Spectrometry (CTD-MS)

3.1

Introduction
Over the past several decades, mass spectrometry has become the preferred method for

identifying peptides and proteins in biomedical applications. However, differentiation of isomeric
residues in peptides still represents a considerable challenge in tandem mass spectrometry.
Collision induced dissociation (CID), which is the most common method for interrogating
peptides, tends to fragment the weakest bonds of a molecule and predominantly results in b- and y
ions for peptides. Whereas b- and y ions provide adequate mass information to identify most amino
acids in peptides, the formation of b- and y ions is not sufficient to differentiate leucine (Leu) and
isoleucine (Ile), which are constitutional isomers. Differentiation of Leu/Ile (Xle) residues is
particularly important to the development of monoclonal antibodies (mAbs) as therapeutic drugs
to treat autoimmune diseases, cancers, and most recently, COVID-19, because incomplete or
inaccurate sequencing can diminish the effectiveness of certain drugs. 150–153
Many techniques have emerged to provide solutions to adequately and reliably differentiate
Xle residues. The formation of metal complexes can provide distinction in dipeptides, 154,155 and
special enzymatic reactions can aid in the differentiation of Xle residues in larger peptides. 156 Lowmass (m/z 86) immonium ions of Xle also can differentiate the two amino acids, but only when
there is a single Xle residue present in the peptide precursor. 157 Derivatization and dimethyllabeling can provide some clarity about Xle residues in CID experiments, but this approach
requires fragmentation at the MS3 level.158 Experiments using consecutive reactions have had
success in differentiating Xle residues, but they require adequately abundant peaks of interest for
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repetitive sequential fragmentation, and they are generally not amenable to the timescales required
for on-line analyses with liquid chromatography.159
Other fragmentation techniques like electron capture dissociation (ECD) and electron
transfer dissociation (ETD) have emerged as complementary techniques to CID. ECD and ETD
both generate abundant c/z ions, which contrasts with the dominant b/y ions in CID. However,
backbone cleavages alone cannot provide the information necessary to distinguish Leu from Ile.
Instead, cleavage of the amino acid side chains can provide the most valuable information for
differentiating Xle residues. This secondary fragmentation is observed in several radical-driven
fragmentation techniques, such as those that first generate a•- and z• fragment ions and
subsequently fragment into d- and w ions, respectively.3,160–162 Recent investigations confirm the
formation of a• ions proceeds through a nitrogen-centered radical, and additional radical migration
produces d ions.163,164
For peptides with charge states 2+ or greater, ECD and ETD tend to produce a series of z•
fragment ions, which can be exploited to produce w ions through multistage and hybrid techniques
like IR-ECD,165 ETD-CAD,166,167 ECuvPD,168 EChcD168 and EtHCD.169,170 However, the
multistage techniques, except for EtHCD, can be cumbersome because they require manual
isolation and fragmentation of each z• ion of interest. EtHCD is different because it applies
supplementary activation to all product ions produced during an ETD event, so it is easier to
implement in an automated manner.169,171 MALDI with in-source decay (ISD) can also generate
d- and w ions to help differentiate Xle residues, but MALDI-ISD has fairly limited sequence
coverage.164,172,173
Hot electron capture dissociation (HECD), which operates with electrons of higher kinetic
energy than traditional ECD, can produce abundant w ions at the MS2 level,34,35,174,175 as
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demonstrated by the neutral losses of •CH(CH3)2 (43.0548 Da) for Leu and •CH2CH3 (29.0391 Da)
for Ile.35 Because HECD readily produces z• ions and seldom generates a• ions, the w ions are
considerably more abundant than d ions. Standard ECD can produce side chain cleavages, too, but
HECD has become the preferred method to distinguish Xle residues. 37,176 Both HECD and ECD
require expensive FTICR instruments, thereby limiting its availability. Whereas there have been
efforts to widen ECD availability by modifying benchtop instruments with electromagnetostatic
cells,177,178 early efforts suffered from relatively poor fragmentation efficiencies,177,178 and
although the efficiencies are now reasonably competitive, the approach still requires multiply
charged precursor ions.168,179–181. HECD also requires multiply charged precursor ions for
fragmentation. Other high-energy fragmentation techniques, like metastable atom activated
dissociation (MAD)87 and UVPD,182 have also demonstrated an ability to produce side chain
cleavages of Xle residues, and they are applicable to charge states as low as 1+. Of all the
techniques, UVPD is closest to widespread adoption, especially because the feature is now
commercially available.
Recently, charge transfer dissociation (CTD), which initiates fragmentation through the
interaction between a beam of high-energy helium cations and an isolated precursor ion, has been
shown to produce radical-driven fragmentation of peptides and oligosaccharides.92,93,95 CTD
builds on the pioneering work by the separate groups of Zubarev36 and Schlathölter.37-38 Both
groups explored keV cation-cation reactions of peptides and showed that the high-energy
activation produces cleavages of all three types of backbone bonds in peptides in addition to side
chain losses.88–90 In previous work from our group, fragmentation of Substance P and bradykinin
with CTD produced backbone cleavages of all types (a/x, b/y, c/z), as well as some notable sidechain losses.92,93 However, none of the previous work on CTD focused on the reliability of side
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chain losses to discriminate between Xle residues. The present study compares the efficacy of
CTD on 1+ and 2+ precursors of model peptides and wild-type peptides to produce either d- or w
ions that can discriminate between Xle residues. The results demonstrate that CTD can provide
quite reliable differentiation of Xle residues for precursors with a charge state of 1+, which was
previously unachievable on a bench-top instrument.
3.2
3.2.1

Experimental
Instrumentation
A modified Bruker AmaZon mass spectrometer (Bruker Daltonics, Bremen, Germany) was

used for the collection of all spectra. The instrument is equipped with a saddle-field fast ion source
mounted directly above the ion trap, and UHP helium was used as the CTD reagent gas. The
instrument modifications are decribed in detail elsewhere.93
3.2.2

Reagents
Model peptides (RGGGGXXGGGGR) were purchased from Pepmic (Pepmic Co., LTD,

Suzhou, China) and reconstituted in a water/methanol/acetic acid mixture (49.5:49.5:1 v/v/v) with
a final concentration of 60 ppm. Wild-type peptides (FVIFLDVK, HFSPEDLTVK) were provided
by the Julian Laboratory (University of California, Riverside, Riverside, CA) All peptides were
synthesized manually following an accelerated FMOC-protected solid-phase peptide synthesis
protocol.183 The peptides were reconstituted in a water/acetonitrile/formic acid mixture
(49.5:49.5:1 v/v/v) with a final concentration of 100 ppm.
3.2.3

Methods
Peptide solutions were introduced to the mass spectrometer using static nanospray with a

voltage of -1500 to -1800 V. Singly and doubly charged precursors were isolated with an isolation
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width of 4 Da. The low mass cutoff was set to m/z 250. CID experiments were performed with an
excitation amplitude between 0.5-2.0 V with SmartFrag disabled and an activation time of 40 ms.
During CTD experiments, the pressure in the main vaccuum chamber was maintained between
1.1x10-5 and 1.2x10-5 mbar. A square-wave voltage of 5-7 kV was applied to the anode of the ion
gun to generate an ion beam of 100 ms duration. Precursor ions were stored at a low mass cutoff
(LMCO) of m/z 250 during CTD, and product ions were stored for an additional 50 ms after CTD
activation to help decrease the chemical background signal from unwanted side reactions. Product
ion spectra were collected for 1-2 minutes in enhanced resolution mode. To negate space charge
effects in product ion spectra, any unreacted precursor ions were resonantly ejected using a 3-7 V
ejection amplitude before mass acquisition. Negative control experiments verified that the
resonance ejection did not produce any collision-induced fragmentation.
3.2.4

Data Processing
Following

conversion

to

mzML

format

using

MSConvert

(http://proteowizard.sourceforge.net/download.html), the spectra were averaged, analyzed, and
annotated using mMass version 5.5.0.184–186 The averaged spectra were normalized to the base
peak, and automated peak picking was performed with a signal-to-noise threshold of 5.0 and an
absolute abundance threshold of 0.3. Annotation of the spectra was performed manually with the
aid of Fragmentor (https://sites.google.com/ucr.edu/jlab/software/fragmentor?authuser=0) to
predict the masses of peptide fragments.
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3.3
3.3.1

Results & Discussion
Model Peptides
Four model peptides with the sequence RGGGGXXGGGGR, where X is either Leu or Ile,

were fragmented by CTD to help establish the propensity for side chain fragmentation of Xlecontaining peptides. Fragmentation of the 1+ precursor by CTD produced a variety of backbone
cleavages and surpassed the sequence coverage offered by CID for the same peptide (Figure 3.1).
In addition to b/y ions, CTD produced a dominant series of a/x ions, similar to observations made
with MAD and UVPD fragmentation.31,24,182 Also, CTD produces several c/z ions, which is similar
to ETD/ECD of the 2+ precursors.23,27 Some neutral losses are observed in the CTD spectrum, and
the most frequently observed neutral loss was for an-NH3 ions. Such neutral losses were also
observed in the previous work on CTD of Substance P.92
CTD of the 2+ precursor produces many of the same product ions seen in fragmentation of
the singly charged precursor, but the 2+ precursor gave a greater number of ammonia losses.
Additionally, many doubly charged product ions are observed in the 2+ spectrum (Figure 3.2).
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Figure 3.1 a) CID and b) CTD spectra of RGGGGLLGGGGR with inset fragmentation maps of the
observed cleavages.
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Figure 3.2 CTD 2+ spectra of a) RGGGGIIGGGGR, b) RGGGGILGGGGR, c) RGGGGLIGGGGR, and
d) RGGGGLLGGGGR with inset fragmentation maps of observed backbone cleavages.

Comparison of the CTD spectra of the four isomeric peptides shows that the expected dand w ions corresponding to the two Xle residues are produced in most, but not all, cases (i.e.,
13/16). The abundances of the d- and w ions are often near the signal threshold level, so the ability
to average multiple spectra significantly enhances the S/N level and the ability to identify these
low-abundance ions. Such averaging might be problematic in situations where ion signals are more
transient, such as with on-line coupling of CTD with HPLC.
Regarding CTD of the 1+ precursor of RGGGGLLGGGGR and RGGGGLIGGGGR, both
peptides produced a d6 ion at m/z 428.1 (Figure 3.3b), which is consistent with a side chain loss
of 43 Da from the a6 ion and is therefore diagnostic for Leu at position 6. Similarly, the peptides
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RGGGGILGGGGR and RGGGGIIGGGGR produced d6 ions at m/z 442.1, which are consistent
with a side chain loss of 29 Da from their respective a6 ions and is diagnostic for Ile at position 6
(Figure 3.3c).
A

RGGGGXXGGGGR

CTD
1013.5

a6
x5

d6

x5

B

CTD
1013.5

d6 (a6-43)

M-99R2+

c112+

II
IL
LI
LL

II
a6

M-99R2+
x5

d6

M-86R2+

IL
d6

a6

M-99R2+
M-86R2+

x5

LI
d6

M-99R2+

M-86R2+

CTD
1013.5

d6 (a6 -29)

C II
IL
LI
LL

a6

x5

LL

Figure 3.3 a) CTD fragmentation of singly charged precursors produces d ions for each of the four model
peptide sequences (RGGGGLLGGGGR in orange, RGGGGLIGGGGR in green, RGGGGILGGGGR in
blue, RGGGGIIGGGGR in pink); b) Magnification of the region for the d6 ion that is diagnostic for Leu in
the sixth position; c) Magnification of the region for the d6 ion that is diagnostic for Ile in the sixth position.

To discriminate Leu from Ile in the seventh position, w6 diagnostic ions should be observed
at m/z 457.1 or m/z 471.2, respectively. As seen in Figure 3.4b, the ion at m/z 457.1 overlaps with
the

13C

isotopic envelope of the M-99R2+ species, which is a characteristic side chain loss for

arginine.34 For all four peptides, the isotopic envelope accompanying the peak at m/z 457.1
includes a 13C isotope peak at m/z 457.6, which confirms the presence of the 2+ product ion, but
complicates the relative contribution of the w6 ion at m/z 457.1. The relative abundance of the M99R2+ peak at m/z 457.1 differs considerably depending on the peptide sequence. For peptides with
Leu in the seventh position, the abundance of the peak at m/z 457.1 is approximately double that
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of peptides with Ile in the seventh position. The abundance of a related side-chain fragment of
arginine at M-86R2+ also correlates with the abundance of the M-99R2+ peak.
The two peptides with Ile in position 7 also produce CTD product ion spectra with a
background or interference peak at m/z 457.1. To help assess the significance of the peak
abundance at m/z 457.1, we therefore assessed the abundance of the w6 ion relative to the z6 ion
from which it derives, and the results are described in more detail under a separate subheading.
The w6 ion at m/z 471.2 is diagnostic for Ile in the seventh position, and this fragment overlaps
with the possible a6+1 ion (Figure 3.4c). However, the relative abundance of the z6-29 peak is
similar for all four peptide sequences, so the presence of a w6 ion for Ile at position 7 cannot be
confirmed without high mass accuracy.
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Figure 3.4 a) CTD fragmentation of singly charged precursors produces w ions for each of the four model
peptide sequences (RGGGGLLGGGGR in orange, RGGGGLIGGGGR in green, RGGGGILGGGGR in
blue, RGGGGIIGGGGR in pink). b) Magnification of the w6 ion diagnostic for Leu in the seventh position.
Though overlapping with the isotopic envelope of M-99R2+, the peak at m/z 457.1 is more abundant for
RGGGGLLGGGGR and RGGGGILGGGGR than the other sequences. c) Magnification of the w6 ion
diagnostic for Ile in the seventh position shows no noticeable difference in the relative abundance of the
ion at m/z 471.2.

Fragmentation of the 2+ precursors also produced d- and w ions, which are complementary
to those observed in the 1+ spectra. A d6 ion at m/z 428.1, which is diagnostic for Leu, appears to
be more abundant for RGGGGLLGGGGR than for the other peptides, but this peak is generally
of too low abundance to be a reliable indicator of the amino acid identity in the sixth position. A
d6 ion diagnostic for Ile in the sixth position at m/z 442.1 is observed for both RGGGGIIGGGGR
and RGGGGILGGGGR (Figure 3.5c). However, the relative abundances of the expected and
decoy (not expected) peaks do not provide the level of confidence one requires for de-novo
sequencing, so this d ion is not as reliable as for the 1+ precursor. The reliability of d ions in the
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1+ spectra compared to the 2+ spectra presumably derives from the fact that a- and d ions are
typically more abundant in CTD spectra of 1+ peptides.34
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Figure 3.5 a) CTD fragmentation of doubly charged precursors produces d ions for each of the four model
peptide sequences (RGGGGLLGGGGR in orange, RGGGGLIGGGGR in green, RGGGGILGGGGR in
blue, RGGGGIIGGGGR in pink). b) Magnification of the d6 ion diagnostic for Leu in the sixth position.
The peak at m/z 428.1 is somewhat more abundant for RGGGGLLGGGGR than the other peptides but does
not appear to be a reliable indicator of Leu in the sixth position. c) Magnification of the d 6 ion diagnostic
for Ile in the sixth position shows a greater abundance for RGGGGIIGGGGR and RGGGGILGGGGR over
peptides without Ile in the sixth position.

The M-99R2+ ion observed in the 1+ spectra is absent in the 2+ spectra, which allows for
more confident assignment of the w6 ion at m/z 457.1 (Figure 5b). Although the ion at m/z 471.2
still overlaps with the isotopic envelope of the a6 ion in the 2+ spectra, the spectra show significant
differences in the relative abundances among the four peptides. For the peptides with Ile in the
seventh position, the abundance of the w6 peak at m/z 471.2 is approximately equal to the
abundance of the a6 ion. In contrast, for peptides with Leu in the seventh position, the decoy peak
at m/z 471.2 is half the abundance of the a6 peak (Figure 3.6c).
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Figure 3.6 a) CTD fragmentation of doubly charged precursors produces w ions for each of the four model
peptide sequences (RGGGGLLGGGGR in orange, RGGGGLIGGGGR in green, RGGGGILGGGGR in
blue, RGGGGIIGGGGR in pink). b) Magnification of the w6 ion diagnostic for Leu in the seventh position.
c) Magnification of the w6 ion diagnostic for Ile in the seventh position. Though overlapping with the
isotopic envelope of a6, the peak at m/z 471.2 is more abundant for RGGGGIIGGGGR and
RGGGGLIGGGGR than the other sequences.

Information gathered from both the CTD spectra of 1+ and 2+ precursors of the different
peptides suggests that discrimination between Leu/Ile is possible through both d6- and w6 ions,
which originate from cleavages between the two Xle residues. Other potential diagnostic ions for
Xle differentiation, such as d7- and w7 ions were also investigated, but the abundances were either
too small or too variable to be reliable. In the four model peptides, cleavages between the Gly and
Xle residues resulted in low abundance z7- and w7 ions. In contrast, N-terminal a7 ions—which
also form between Gly-Xle residues—were readily abundant for all four model peptides. However,
the abundance of the corresponding d7 ions were still insufficient to permit confident assignment
of the Xle isomers. For these reasons, Xle isomers in the seventh position of the model peptides
were therefore only reliably accessed from the C-terminus and through the w6 fragments.
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3.3.2

Diagnostic d/a and w/z Abundance Ratios for Xle Identification
As described above, the abundance of the diagnostic d- and w ions of the Xle residues is

often sufficiently small as to create ambiguity about their relevance. To create a more objective
assessment of the presence or significance of peaks that could be attributed to d- or w ions, we
developed a simple method to compare the abundance ratios of d- and w ions to the corresponding
a- and z ions from which they derive. In the proposed approach, if the corresponding a- or z ion is
below an arbitrary threshold, the abundance of a different—but structurally and spectrally
related—ion is used as a comparison to the selected w ion. For example, most of the z6 ions for the
2+ model peptides fell below the threshold for peak identification, so the corresponding a6 ion was
used to compare abundance ratios, as shown in Figure 3.7b. The d/a- or w/z abundance ratios are
then calculated for both the expected fragments—such as the loss of 43 Da for Leu, if a Leu is
present—and a decoy fragment, such as the loss of 29 Da, if Leu is present. Ideally, the decoy
fragment should not be observed at all, but most of the CTD spectra contain some level of
background signal or isobaric interference at the decoy position, hence the need for d/a- and w/z
abundance comparisons.
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Figure 3.7 Abundance ratios for expected w6 fragments and decoys for a) 1+ and b) 2+ model peptides.
Asterisks indicate pairs that are significantly different (t-test, P<0.05, power>0.9, n=5).

For the four model peptides, the expected fragments had a significantly higher abundance
ratio (t-test, P<0.05, power>0.9) than the hypothetical decoy in thirteen of the sixteen cases (81%).
Eight comparisons for the d/a ion pairs are shown in Figure 3.8. The results of the w/z ion pairs
are shown in Figure 3.7. As an example, the w6 fragment for RGGGGIIGGGGR1+ has average
abundance ratios relative to the z6 fragment of 2.12 and 0.61 for the expected and decoy peaks,
respectively. Using a ratio of 1 as a threshold would accurately identify Ile in the sixth position. In
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a more challenging case, like the w6 ion for RGGGGILGGGGR1+, the average abundance ratios
for w6/z6 ion pairs were 1.79 and 1.58, respectively, for the expected and decoy fragments. The
lack of significant difference between the expected and decoy peaks in this case make it impossible
to distinguish the Xle residues. Our findings are consistent with prior work in that when an Xle
residue is suspected, the abundance of the d- or w ion for the expected side chain loss is
significantly greater than the abundance of the decoy loss.35 However, the d- or w ions are only
reliably present about 80% of the time in the model peptides, so the Xle residues are sometimes
not resolvable.
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Figure 3.8 Abundance ratios for expected d6 fragments (light blue) and decoys (orange) for 1+ (a) and 2+
(b) model peptides. Asterisks indicate pairs that are significantly different (t-test, P<0.05, power>0.9, n=5).

The three exceptions that did not show significant differences between expected and decoy
ion pairs were the d6 ion for RGGGGIIGGGGR1+, the w6 ion for RGGGGILGGGGR1+ and the d6
ion for RGGGGLIGGGGR2+. The d6 ions for RGGGGIIGGGGR1+ and RGGGGLIGGGGR2+
were too low in abundance or too variable to be significantly different from the decoy ion. For
RGGGGILGGGGR2+, the decoy ion of w6 is isobaric with a

13C

ion of a6, which negatively

impacted the abundance ratio. Except for these three cases, the expected fragment had a reliably
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greater abundance ratio than the hypothetical decoy. The results are summarized in a box and
whisker plot in Figures 3.7 and 3.8.
Unfortunately, the d6/a6 ratios are not of similar enough magnitudes for the four peptides
to permit a universal threshold with which to discriminate between Xle residues. For example, for
the 1+ precursor in Figure 3.8A, a threshold d6/a6 value of 0.15 would successfully discriminate
three of the four Xle residues in the sixth position, but a threshold of 0.1 would be required to
identify Ile in the sixth position for RGGGGIIGGGGR1+. For the 2+ precursors, a threshold of 0.2
would correctly identify Leu and Ile in RGGGGLLGGGGR2+ and RGGGGIIGGGGR2+,
respectively, but a lower threshold of 0.1 would be required to resolve the Xle residues in
RGGGGILGGGGR2+ and RGGGGLIGGGGR2+. For these reasons, the use of a general, dataindependent threshold of ~0.2 for de novo peptide sequencing probably only confidently assign
about 50% of the Xle residues. Such discrimination could still be valuable in certain applications.
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Figure 3.9 Abundance ratios for expected fragments and decoys for a) 1+ and b) 2+ FVIFLDVK peptides.
Asterisks indicate pairs that are significantly different (t-test, P<0.05, power>0.8, n=4).
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Figure 3.10 Abundance ratios for expected fragments and decoys for a) 1+ and b) 2+ HFSPEDLTVK
peptides. Asterisks indicate pairs that are significantly different (t-test, P<0.05, power>0.7, n=4).

3.3.3

Wild-type Peptides
Having established that CTD can produce d- and w ions for Xle residues approximately

80% of the time in the model peptides, we then investigated two additional wild-type peptides that
had more complex sequences. The first peptide, HFSPEDLTVK, from the human alpha-crystallin
A chain, has a single Leu residue at position 7. CTD spectra of the 1+ and 2+ precursors are shown
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in Figure 3.12. Like the model peptides, CTD of the singly charged precursor produced an
abundant array of a/x-, b/y-, c/z-, and d/w ions, but CTD of the doubly charged precursor produced
less-abundant a/x ions. These findings are consistent with previous work on CTD of other
peptides.34 Some additional side chain losses, such as v ions, were also observed in the CTD spectra
of both 1+ and 2+ precursors. Fragment ion maps in Figure 3.13-3.14 help show the observed
fragments.
Reliable d- and w ions diagnostic for Leu can be identified in the 1+ spectra (Figures 3.12b
and 3.12c). Notably, the w4 ion abundance exceeds that of the z4 ion from which it derives,
suggesting CTD can achieve similar energies or follows similar fragmentation mechanisms as
HECD. Energy-dependent studies of the formation of w ions with HECD showed that the relative
abundance of w ions increases with higher electron energies.38 Many secondary ions reported with
HECD are about one-third to one-half the abundance of the z ions from which they derive, but at
higher energies, the w ion abundance can match or exceed the abundance of its corresponding z
ion.35,38,39. The 2+ precursor did not produce any a ions, which probably explains why no d ions
were observed either. In the CTD spectrum of the 2+ precursor, the 1+ product ion at m/z 401.2
has an ambiguous identity because the w ion for Leu overlaps with a y72+ ion (Figure 3.12c). We
know the y72+ ion is present because of the spacing of the isotope envelope is 0.5 Da.
In addition to the side chain losses for Leu, side-chain losses are observed for other amino
acids in the sequence, too. In the singly charged species (Figure 3.13a), w ions are observed for
glutamate and serine, and d ions are observed for glutamate and aspartate. At m/z 856.4, and m/z
943.5, v ions are observed for serine and phenylalanine, respectively. In the doubly charged species
(Figure 3.13b), a w ion is observed for threonine and a v ion is observed for aspartate. These
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fragments suggests that CTD may be able to differentiate other isomeric amino acids through these
unique side-chain losses.

Figure 3.11 a) Stacked CTD spectra of HFSPEDLTVK with triangles representing the resonantly ejected
precursor and diamonds representing the CTnoD product. b) Head-to-tail magnification of the a7 d7 ion
with 1+ precursor in pink and 2+ precursor in green. c) Head-to-tail magnification of the z4
w4 ion. In
the 2+ spectra, the w4 ion falls at the same m/z value as the y72+ ion.
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Figure 3.12 Backbone cleavages from CTD of the a) 1+ precursor and the b) 2+ precursor of
HFSPEDLTVK.

The second wild-type peptide, FVIFLDVK, has both a Leu and an Ile present in the
sequence. Many types of backbone cleavages are present in the CTD spectra of the 1+ and 2+
precursors, but a- and d ions are again absent in the 2+ spectra (Figure 3.14-3.15). For the 1+
precursor, a low-abundance, d5 ion, diagnostic for Leu, is questionable at m/z 549.2, and the d3 ion
for Ile cannot be identified because it falls in the low-mass region of the spectrum that contains
high chemical background (Figure 15b). However, a reliable w4 ion at m/z 415.2 is present in the
spectra from both precursors, and the w4 fragment is slightly more abundant than the corresponding
z4 ion in both cases (Figure 15c). A w6 ion, diagnostic for Ile, is also present in both spectra.
Notably, a low-abundance w6b ion is present in the 1+ spectra of FVIFLDVK (Figure 15d), which
is a loss of -15 Da from the corresponding z ion. Since Ile has a forked side chain, there is a
possibility for a loss of -CH3 from the corresponding z ion, which generates a wnb ion. However,
a loss of -CH3 from Ile is generally unfavored, so this particular type of ion is rarely reported for
Ile.161 Other side-chain losses (w/d- and v ions) are also observed for phenylalanine, valine, and
aspartic acid (Figure 3.13).
Diagnostic d/a and w/z abundance ratios for Xle identification were calculated for both
wild-type peptides. In each instance, the expected fragment ratio was significantly different from
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the decoy ratio (Figures 3.9-3.10). This provides an added level of confidence in identification of
the Xle residues within the selected peptides.

Figure 3.13 Backbone cleavages produced by CTD of the a) 1+ precursor and the b) 2+ precursor of
FVIFLDVK.
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Figure 3.14 a) Stacked CTD spectra of FVIFLDVK with triangles representing the resonantly ejected
precursor and diamonds representing the CTnoD product. b) Head-to-tail magnification of the a5 d5 ion,
diagnostic for Leu, with 1+ spectra in blue and 2+ spectra in purple. Neither a5- nor d5 ions are observed
in the 2+ spectra. c) Head-to-tail magnification of the z4 w4 ion, which is characteristic of Leu. d) Headto-tail magnification of the z6
w6 ion, which is diagnostic for Ile. A w6b ion is also observed in the 1+
spectra.

3.4

Conclusions

For the fragmentation of model and wild-type peptides, CTD provides fragment ion types that are
comparable to other high-energy techniques, like ECD, ETD, and UVPD. Especially for the 1+
precursor, CTD produces quite reliable a- and x ions, which are commonly observed with UVPD
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of 1+ precursors. For the 2+ precursors, CTD provided less-abundant a- and d ions, but moreabundant c- and z ions, which are generally more abundant in ECD and ETD spectra of multiply
charged precursors.
Important side chain cleavages are also observed with CTD, marking another similarity to
other dissociation methods like HECD—which reliably produces w ions for multiply charged
peptides35,161—and 157 nm UVPD, which produces both d- and w ions for singly charged
peptides.187,188 CTD produces both d- and w ions from either 1+ or 2+ charged precursors on a 3D
ion trap instrument, giving a slight advantage over other techniques which require multiply
charged precursors and more expensive instruments, like high-field FTICR mass spectrometers.
Reliable differentiation between Leu and Ile was possible through the generation of d/w ions that
are diagnostic for Leu or Ile, although differentiation was not always unambiguous. Fragments
such as d- and w ions were observed for about a third of the amino acid residues in each peptide,
and these results indicate that CTD can contribute to the differentiation between other isomeric
amino acids, such as through d- and w ions for aspartic acid/isoaspartic acid and d- and w ions for
valine/norvaline.
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4

Differentiating Aspartic Acid Isomers with Charge Transfer Dissociation
Mass Spectrometry (CTD-MS)

4.1

Introduction
Proteins in the human body perform various and vital functions to maintain the body’s

proper working order. Most proteins have relatively short lifetimes, on the order of days or weeks,
and are regenerated frequently. However, other proteins, like elastin, collagen, nuclear pores, and
eye lens crystalline, have long lifetimes on the order of decades. 189–191 Throughout a protein’s
lifetime, spontaneous modifications such as oxidation, isomerization and epimerization can occur,
and these modifications can accumulate in long-lived proteins that are not regularly replaced.192
These accumulated modifications can lead to conformational changes in the protein structure,
aggregation and loss of function, which can be a root cause of many debilitating diseases that are
linked to degeneration. Alzheimer’s is one such neurodegenerative disease that is marked by a loss
of synaptic function in the brain and can be linked to aggregations of amyloid beta and tau
proteins.193,194 Similarly, other degenerative diseases—like Parkinson’s, Huntington’s, cystic
fibrosis and certain cancers—likely originate from protein misfolding and subsequent
aggregation.195 Cataracts, which is the leading cause of blindness worldwide, develops due to the
breakdown of eye lens crystalline over time and results in an altered protein structure that is less
transparent than the properly folded form.196,197 In addition to the importance in studying
degenerative diseases, knowledge of protein structure and post translational modifications is
important to the development of therapeutic antibodies, especially because loss of function can
decrease antigen binding, thereby limiting the effectiveness of treatments.198,199
All twenty amino acids that make up proteins within the human body can undergo
racemization from the preferred L-form to the D-form. However, aspartic acid racemizes at least
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four times more quickly than other amino acids. 200 Due to its rapid racemization, D-Asp
isomerization has been more widely observed in biological systems and has been more widely
studied.201–203 It is well known that aspartic acid in a protein—whether from translation or from
deamidation of asparagine—is prone to forming a stable succinimide ring intermediate following
intra-nucleophilic attack. Subsequent ring opening and/or stereoinversion converts aspartate to one
of four isomeric forms: L-Asp, D-Asp, L-isoAsp, and D-isoAsp.204 All four forms of Asp have
been detected in the human brain, although L-Asp is the original form produced via
translation.205,206 Accumulation of D-Asp is often observed in long-lived proteins, and D-Asp is
linked to age related diseases like cataracts.207–209 Additionally, D-Asp is found at higher
concentrations than L-Asp in the brains of Alzheimer’s patients.210 In fact, the link between aging
and racemization is so well formed that measurements of D-enantiomers can be used as a tool to
estimate the age of biological material in forensic and archeologic applications. 202,211
Many different mass spectrometry methods have attempted to differentiate the four forms
of Asp, with varying degrees of success.212,213 Although they are isomeric, the structural
differences between Asp and isoAsp are distinguishable because they can produce some unique
fragment ions. Commonly observed b+H2O and y-46 ions have been reported in fast atom
bombardment mass spectrometry (FAB-MS),214 low-energy collision induced dissociation
(CID),215,216

high-energy CID,217

matrix-assisted laser desorption/ionization (MALDI)

photodissociation (PD),213 and MALDI post-source decay (PSD).213 Electron transfer dissociation
(ETD) and electron capture dissociation (ECD) produce reliable c+57 and z-57 ions that arise from
cleavage between the C and the additional carbon incorporated into the backbone of isoAsp
residues.218–224 Additionally, side chain cleavages in the form of w-, d-, and v ions are often only
observed for Asp residues.213,217
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Whereas unique ions characteristic of isoAsp are preferable for identification, differences
in relative ion abundances can also provide insight into the identity of the questioned residue. FABMS225 and CID226 produce less abundant b- and a ions and more abundant y ions at isoAsp residues
relative to Asp, and Asp also tends to form a more intense immonium. 227 MALDI free-radical
initiated peptide sequencing (FRIPS) provides differences in the abundance of neutral losses—
particularly H2O and CO2—between Asp and isoAsp, and generally favors more intense peaks for
Asp residues.213 Also, ETD has been shown to provide more intense z ions for isoAsp relative to
Asp.221
Unique ions and differences in relative ion abundances can both distinguish Asp and
isoAsp residues from one another in peptides; however, such diagnostics are not as common at
differentiating L- and D epimers of Asp and isoAsp because the isomers are structurally identical
and only differ in their stereochemistry. One method that has shown great potential for chiral
differentiation is radical-directed dissociation (RDD).71,73,228–230 RDD is a radical based
fragmentation technique that generates a radical through site-specific cleavage of a carbon-iodine
bond by photodissociation.72 Peptides are first modified to include a C-I bond by attaching a
chromophore, such as iodobenzoic acid to the N-terminus or by inserting an iodine into an existing
tyrosine residue. The peptide is then ionized, isolated in a 2D or 3D ion trap and subjected to a
266-nm pulsed laser to induce photodissociation of the C-I bond and create a radical. The radical
product is then subjected to collisional activation to create radical-induced cleavages.73 RDD
spectra often show significantly different spectra for L- and D epimers of the same peptide
sequence, with many peaks having different relative abundances between the two epimers. To
quantitate this degree of differentiation, an R value can be calculated, which compares the intensity
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ratio of a pair of peaks in two spectra of an isomeric species according to Equation 4.1.231 RA and
RB represent the pair of peaks with the largest difference in abundance between the two epimers.

𝑹𝒄𝒉𝒊𝒓𝒂𝒍 =

𝑹𝑨
⁄𝑹
𝑩

Equation 4.1

R values greater than one indicate some degree of differentiation, and larger R values indicate a
greater degree of confidence in the discrimination. CID typically gives relatively low R values for
differentiating amino acid epimers, ranging from 1.0-7.0.73 ETD-CID gives slightly higher R
values than CID, ranging from 2.0-9.0, while RDD can provide R values from 7.0-30.0 for
differentiating amino acid epimers.73,232 RDD’s ability to generate the largest R values has made
it the preferred fragmentation method for differentiating L- and D epimers of aspartic acid due to
its larger degree of chiral differentiation over other methods.
Charge transfer dissociation (CTD) also generates radical species in peptides through
interactions of protonated or deprotonated precursors with a beam of kiloelectronvolt helium
cations, which effectively abstract an electron from the precursor.92 CTD is effective at providing
numerous backbone cleavages of peptides—including a-, b-, c-, x-, y-, z-, d-, w- and v ions—the
last three of which are useful side chain losses. 93 The radical-driven nature of fragmentation in
CTD implies that it might perform similarly to RDD for the discrimination of L- and D epimers of
Asp. Additionally, the numerous fragments produced by CTD could provide distinction between
Asp and isoAsp. The current work therefore investigated peptides containing isomers of Asp,
derived from crystallin protein, by CTD to identify discriminatory features of the spectra that can
provide distinction between the different isomeric forms.
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4.2
4.2.1

Experimental
Instrumentation
A Bruker amaZon 3D ion trap mass spectrometer, modified to perform CTD, was used for

all experiments. The instrument modifications are described elsewhere. 93 UHP helium was used
as the CTD reagent gas.
4.3

Samples
Synthetic versions of crystallin peptides were synthesized following an accelerated FMOC-

protected solid-phase peptide synthesis protocol183 and provided by by the Julian Laboratory
(University of California Riverside, Riverside, CA). Each peptide was reconstituted in a
water/acetonitrile/formic acid mixture (49.5:49.5:1 v/v/v) with a final concentration of 100 ppm.
The peptides included FVIFLDVK and HFSPEDLTVK, which are found in sheep228 and human74
αA Crystallin, and GYQYLLEPGDFR, which is common to mouse βB1 Crystallin.233 Each
peptide was fabricated in four different versions, with either L-Asp, L-isoAsp, D-Asp and DisoAsp as the D residue.
4.4

Method
Peptide solutions were ionized by a static nanospray source with a voltage of 1500-1800 V.

An isolation width of 4 Da was used during precursor isolation, and the low mass cutoff was set
to m/z 250 during CTD. For comparison experiments, CID experiments were performed with a
reaction amplitude between 0.5-2.0 V for 50 ms, with Smartfrag disabled. For CTD experiments,
the pressure in the vacuum chamber was maintained at ~1.2x10 -5 mbar, and the ion beam was
pulsed on for 100 ms with a voltage of 5-7 kV. The ions gain ~80% of the anode potential so have
between 4-5.6 keV of kinetic energy. Product ion spectra were collected for 1-2 minutes in
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enhanced-resolution mode. After CTD, unreacted precursor ions were removed using resonance
ejection at the MS3 level to minimize space-charge effects and improve the mass accuracy and
signal-to-noise ratio.
4.5

Data Analysis
Spectra

were

converted

to

mzML

format

using

MSConvert

(http://proteowizard.sourceforge.net/download.html) and worked up in mmass. 184–186 The
averaged spectra were normalized to the base peak and automated peak picking was performed
using a signal-to-noise threshold of 5.0 and an absolute intensity threshold of 0.3. Fragmentor
(https://sites.google.com/ucr.edu/jlab/software/fragmentor?authuser=0) was used to predict the
masses of peptide fragments and aid in annotation. R values of epimers were calculated using
RIsomer (https://sites.google.com/ucr.edu/jlab/software/r-isomer?authuser=0). ANOVA was
performed with SPSS 22 to identify significantly different peaks between isomers and epimers of
aspartic acid.
4.6

Results & Discussion
CTD fragmentation produced numerous types of backbone and side chain cleavages for

the peptides studied and provided 100% sequence coverage, in most cases. In addition to the band y ions commonly observed with CID, CTD produced a series of a-, x- and z ions and some cions (Figure 4.1). Aligned with previous observations, many of the backbone cleavages were
radical species, like a+1, x+1, and z+1 ions, that are typically found in other high energy
fragmentation techniques.92,94 Generally, increasing the charge state of the precursor ion increased
the number of observed fragments. CID produced primarily b- and y ions, as well as neutral losses
and a few a ions.
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Figure 4.1 CTD spectra of all-L a) FVIFLDVK b) GYQYLLEPGDFR and c) HFSPEDLTVK with inset
fragment maps. Triangles represent the resonantly ejected precursor and diamonds represent the CTnoD
product ion.

4.6.1

L-Asp v. L-isoAsp
Before comparing the CTD spectra of Asp and isoAsp, we first identified commonly

observed isoAsp identifiers within other methods of tandem mass spectrometry, as outlined in
table 4.1. After annotating the CTD spectra of peptides containing either Asp or isoAsp, we
compared the fragments obtained through CTD to those observed using other methods. For
instance, the b6 ion in FVIFLDVK was about 80% less intense for the isoAsp version relative to
the Asp version. However, there was no meaningful difference in ion abundance of the b10 ions for
the Asp and isoAsp versions of GYQYLLEPGDFR, and the b6 ion in HFSPEDLTVK was actually
more intense for isoAsp than for Asp, which is in contrast to the trend observed using CID226 and
FAB-MS.225 Generally, CTD produces a ions that are enhanced for Asp residues, and CTD
produces y- and z ions that are enhanced for isoAsp residues. The a ions for Asp in FVIFLDVK1+
and GYQYLLEPGDFR2+ are significantly more intense (p<0.05) than the same ions for isoAsp
residues. The a10 ion for GYQYLLEPGDFR1+ was also observed to be slightly more intense for
Asp than isoAsp, but the difference was less significant (p=0.114). These results are similar to
those obtained with FAB-MS.225
Whereas enhanced a ions in a CTD spectrum can help confirm the presence of Asp residues
in a peptide, enhanced z- and y ions are helpful in identifying isoAsp residues . Regardless of the
precursor charge state, the z3 ion for FVIFLDVK was significantly more intense (p<0.05) for the
sequence containing isoAsp rather than Asp in the sixth position. Likewise, the z5 ion was
significantly more intense (p<0.05) for isoAsp relative to Asp in HFSPEDLTVK 2+. These
observations are consistent with those of MALDI-FRIPS213 and ETD.221 The z3 ion for
GYQYLLEPGDFR was too low in abundance for confident assignment. When observed, y ions
were also significantly more intense (p<0.05) for isoAsp relative to Asp in all but one case. In that
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exception, the y3 ion is isobaric with the 13C peak of the b3 ion of FVIFLDVK at m/z 360.2. The
general trends observed for Asp and isoAsp in the various CTD spectra are consistent with those
reported for CID226 and MALDI-PSD213.
Table 4.1 contains a summary of CTD observations and the common isoAsp identifiers
reported in the literature and only apply to L-forms of Asp/isoAsp; D-foms of Asp/isoAsp provide
a more complicated problem that will be addressed in a different section.
Table 4.1 Commonly observed isoAsp identifiers relative to Asp among different dissociation methods
isoAsp Identifiers

Observed with:

CTD observations:

Decreased b ions

FAB-MS225

Sometimes

Decreased a ions
Increased y ions
Increased z ions
b+H2O, y-46

c+57, z-57
Decreased -CO2

CID226
FAB-MS225
CID226
MALDI-PSD213
MALDI-FRIPS213
ETD221
CID215–217
FAB-MS214
MALDI-PSD213
MALDI-PD213
ECD218–220
ETD223,224,234
MALDI-FRIPS213
MALDI-FRIPS213

Observed
Sometimes
Observed
Not observed

Inconsistent
Not observed

The unique b+H2O and y-46 ions characteristic of isoAsp were not observed with CTD,
but a single c5+57 ion was observed at m/z 694.4 for FVIFLDVK2+ (Figure 4.2). This unique
cn+57 ion type was first observed with ECD, and it has become a reliable diagnostic ion to
differentiate Asp and isoAsp.220 Because it cleaves between the C and the extra carbon inserted
into the peptide backbone of isoAsp residues, the fragment at cn+57 cannot be produced when an
Asp residue is present. Notably, we observe this unique ion present in both the L form and D form
of isoAsp in FVIFLDVK, which suggests that the mechanism is not sensitive to chiral differences.
The c5+57 fragment was only observed for this particular peptide, so although we demonstrated
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that CTD is capable of producing these diagnostic ions that are common to ECD and ETD, the
formation of this type of product ion is not guaranteed.

w6

c 5+57

z6

490.8
CTD

Figure 4.2 Comparison of the D epimers of FVIFLDiVK (blue) and FVIFLDVK (orange). The peak

at m/z 694.4 for c5+57 is unique to the isoAsp residue.
4.6.2

L/D Epimers of Asp
To differentiate L- and D- epimers of aspartic acid using CTD, we first identified peaks

that were significantly different in abundance between the epimers. We also used CID spectra of
the same peptides as a benchmark. Significant differences in ion abundances were determined
using one-way analysis of variance (ANOVA) using Asp epimerization as the fixed factor. Each
test included three replicate measurements of each peptide. To be considered for one-way
ANOVA, peaks had to be present, with a signal-to-noise (S/N) ratio greater than 5, in at least one
spectra of the two epimers. The number of significant differences and the significance of the
differences (as assessed by the significance, p, of the F values) were both considered as metrics
for the reliability of epimer discrimination.
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Fragmentation of singly charged peptide precursors produced a similar number of peaks
that contained significant (p<0.05) abundance differences in both CTD and CID spectra. However,
for the doubly charged peptides, CTD produced a greater number of significantly different peaks
than CID (Table 4.2). The identities of the significant peaks indicate a few trends in the types of
ions that may be useful for discriminating between L/D forms of aspartic acid. The most promising
trend is a potential side chain loss (bn-45D) from aspartic acid. When observed, the bn-45D peak
is more intense for the D-epimer (Figure 4.3). Unfortunately, without higher mass resolution, we
cannot distinguish bn-45D ions from an-NH3 ions because they are nominal isobars. Whether the
ion is the loss of the aspartic/isoaspartic acid side chain or a neutral loss of ammonia is less
important than the observation that the peak occurs at a greater abundance for one epimer over the
other; the peak can still be used to positively identify the D epimer. If the ion is in fact the loss of
the aspartic acid side chain, this observation suggests the side chain is more readily lost from the
D form of this residue.
Other neutral losses from backbone cleavages, like -H2O and -CO2, are observed to be
more abundant for the D epimer than the L epimer in several cases. For example, b10-CO2 is more
abundant for D epimers of GYQYLLEPGDFR and GYQYLLEPGDiFR, whereas an x5-CO2 is
more abundant for the D epimer of HFSPEDLTVK. Additionally, the z3-H2O and z5-H2O ions are
more abundant for the D epimers of FVIFLDVK and HFSPEDLTVK, respectively. Although not
observed in every case, these neutral losses may be preferred for the D epimers and thus could be
helpful in correctly identifying the chirality of Asp residues. We also observed significant
differences in ion abundances for peaks that are not as obviously related to the proximity of the D
residue. For example, the z4 fragment for FVIFLDVK is significantly more intense for the version
containing D-Asp relative to L-Asp, but this cleavage site is one amino acid residue removed from
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the site of epimerization. Since the epimers differ only in their stereochemistry, these differences
in ion abundances using CTD indicate that fragmentation behavior is sufficiently sensitive to
conformational changes as to be readily observable at cleavage sites not directly related to the site
of epimerization.
Table 4.2 Numbers of significantly different peaks for different precursor
charge states and dissociation methods for the discrimination of
L- and D epimers of Asp and isoAsp
Sequence

CTD 1+

CID 1+

CTD 2+

CID 2+

b

729.4
CTD

729.4
CTD

c
b10-45D/10-NH3

a

b10-45D/10-NH 3

w6

b6-45D/a6 -NH3

490.8
CTD

c5+57

FVIFLDVK
30
25
51
12
FVIFLDiVK
24
45
51
13
GYQYLLEPGDFR
9
--b
40
18
GYQYLLEPGDiFR
48
--b
50
25
HFSPEDLTVK
19
20
83
15
HFSPEDiLTVK
19
11
55
20
aThe sequences of the peptides are identified by single letter codes with Di representing isoaspartic acid.
Bold, underlined residues correspond to the site of epimerization.
Significance assessed using one-way ANOVA using D epimer as the fixed factor and p<0.05.
b
CID data was not collected in this case.

Figure 4.3 CTD of L- and D epimers of a) FVIFLDVK b) GYQYLLEPGDFR and c) GYQYLLEPGDiFR
showing more intense ions corresponding to bn-45D/an-NH3 for the D epimer of Asp (blue) relative to the
L epimer (orange).

To quantitate the degree of chiral discrimination possible with CTD, R values were
calculated for pairs of epimers with paired peak lists that were already determined to be
significantly different between the spectra of the two epimers, as identified through one-way
ANOVA. The R values shown in Tables 4.2 and 4.3 were calculated from the mean of three
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replicate peak abundances for each peak for each epimer. In some cases, CTD produced one or
more unique peaks for one epimer, such as the b6-45D/a6-NH3 peak for FVIFLDVK in Figure 4.3,
and the a9-H2O ions in Figure 4.4. CID did not provide any unique peaks for one peptide relative
to its epimer.
Only ions present in both spectra and greater than 5% were considered for R value
calculations. In almost every case, CTD produced a larger R value than CID. In fact, the R values
obtained for CTD matches or outperforms RDD, which typically delivers R values in the range of
2.0-30.73,232
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Table 4.3 Maximum R values obtained with CTD and CID for the discrimination of
L- and D- epimers of Asp and isoAsp
1+ charge state
Sequence

2+ charge state

CTD

CID

CTD

CID
1.0
1.0
4.1
5.3
5.0
2.8

HFSPEDLTVK

c8

y8-71K

a8 -NH3

b8 -H2 O

b7

z8

c7

b8

586.8
CTD

y7

x 6+1

FVIFLDVK
5.8
18.5b
9.3
FVIFLDiVK
10.2
11.0b
16.8
GYQYLLEPGDFR
1.6
--c
2.8
GYQYLLEPGDiFR
19.9
--c
48.2
HFSPEDLTVK
26.3
1.2
69.8
HFSPEDiLTVK
41.0
7.9
37.5
aThe sequences of the peptides are identified by single letter codes with Di representing isoaspartic acid. Bold,
underlined residues correspond to the site of epimerization.
bThe unexpectedly large R values present with CID may be attributed to unintentional differences in the
accumulation times between two CID spectra during data collection.
c
CID data was not collected in this case.

a9-H 2O

b8

c8

b8-H2O

a 8-NH3

c7

x 6+1

b7

z8

y8

y8-71K

y7

b6

586.8
CTD

Figure 4.4 CTD of L- (orange) and D (blue) epimers of HFSPEDLTVK2+ showing the differences in relative
peak abundances between spectra. The peaks that vary the most between the two spectra are the y 8-71K
ion and the x6+1 ion, which gives an R value = 69.8. Additionally, the a9-H2O ion is unique to L-Asp. The
peaks of interest are indicated by boxes.

The identities of the pairs of peaks used to calculate R values were also investigated to see
if they were easily related to the altered Asp or isoAsp residues. Epimerization can disturb the
three-dimensional structure of the entire peptide, so differences in fragment ion abundances may
not always be obviously related to the Asp residue. In fact, with CID, most of the peaks are
backbone cleavages or involve neutral losses unrelated to the Asp/isoAsp residue, so there is little
or no information one can gain about what types of cleavages can be enhanced or hindered with
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L/D epimers or how differences in fragment ion abundances can be used to provide predictions for
new Asp-containing peptides. For CID, there are only two cases in which at least one of the peaks
are adjacent to the Asp/isoAsp residues. For the L- and D epimers of HFSPEDLTVK, a b6 ion on
the C-terminal side of Asp is significantly different, and for HFSPEDiLTVK, a y4 ion on the Cterminal side of isoAsp is significantly different. For CTD, many of the significant peaks are
adjacent to, or one residue removed from, the Asp/isoAsp residue (Table 4.4).
Table 4.4 Maximum R values and other related peaks for the discrimination of L and D epimers of Asp
and isoAsp obtained with CTD and CID for precursor peptides with different charge states.a Epimers
with unique fragments in CTD were excluded from these calculations.
CTD
1+ charge state
Sequence

R
value

FVIFLDVK

5.8

FVIFLDiVK

10.2

GYQYLLEPGDFR

1.6

GYQYLLEPGDiFR

19.9

HFSPEDLTVK

26.3

HFSPEDiLTVK

41.0

Related peaks
x6-H2O
b5
a5
c4-15V
M•-45D2+
x2
M-H2O2+
y6-CO2
M•-59E-56L
x5
c6

M•-45D-43L

CID
2+ charge state

1+ charge state

R
value

Related
peaks

R
value

9.3

a7
z5-58K2+
b6
b3
M-CO23+
b3

18.5b

y9-H2O
y52+
y8-71K
x6+1

16.8
2.8
48.2
69.8
37.5

z6
a72+

Related peaks

2+ charge state
R
value

Related peaks

1.0

--c

Unassigned
y4
M-H2O
unassigned
--c

4.1

y8
unassigned

--c

--c

5.3

1.2

b9
y8

5.0

y8
b7
b6
unassigned

7.9b

M-H2O-NH3
unassigned

2.8

11.0b

1.0

M-H2O
y4

aThe

sequences of the peptides are identified by single letter codes with Di representing isoaspartic acid. Bold, underlined
residues correspond to the site of epimerization.
bThe unexpectedly large R values present with CID may be attributed to unintentional differences in the accumulation times
between two CID spectra during data collection.
cCID data were not collected in this case.

Herein, CTD demonstrates a high degree of chiral discrimination, similar to RDD and
ETD. Further, we observed that D-epimers produce more abundant bn-45D/an-NH3 ions that can
provide confidence in assigning the chirality of an Asp residue in an unknown peptide. Though
this specific ion is not always observed, the high R values obtained with CTD can be used to
identify peptides with epimerization present in the sequence. Comparisons with standards of
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known chirality could then provide additional clarity in identifying the location and type of
epimerization
4.6.3

a/x Ion Formation
The abundance of a+1 radical ions in the CTD spectra are reminiscent of those produced

by UVPD,92 which indicates that the fragmentation mechanism in CTD could follow similar
homolytic cleavage of the C𝛼-C bond to form the a+1 ions, as hypothesized in UVPD.188 In CTD,
the homolytic cleavage of the C𝛼-C bond may be instigated by ionization of the nearby lone pair
on the carbonyl oxygen atom, in a similar mechanism to that proposed for metastable atomactivated dissociation (MAD).87 Among the two isoforms of the three peptides studied, a+1 ions
were observed in every case. More frequently than the a+1 ions, several x+1 ions were also
observed for each peptide. These findings are consistent with CTD of other low-charge state
peptides using CTD.50
Among the fragmentation methods capable of producing a/x ions and their radical
counterparts, the a+1 is most commonly observed. For example, in UVPD, absorption of a 157
nm photon leads to homolytic cleavage to produce a+1 and x+1 ions. These primary fragments
then undergo hydrogen elimination to form the even electron a/x species.182,187,188 In addition to
this possible pathway, CTD could also begin with the radical cation localized on the carbonyl
oxygen—as described above—or localized on the amide nitrogen, as described by Kjeldsen and
coworkers for EDD.235 As proposed in scheme 1, 𝛼-cleavage of the amide backbone would create
an even-electron a ion and an x+1 ion. Since both a+1 and x+1 species are observed, it is possible
that fragmentation could proceed via various competing pathways in CTD. However, given that
x+1 ions are generally more abundant than a+1 ions, excitation of, or radical location on, the
amide nitrogen may be preferred in this case. In principle, the x+1 ions with a radical on the
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carbonyl carbon in Scheme 1 could readily form z-type ions through the loss of a neutral molecule
of isocyanic acid, or CONH.

Scheme 4.1 Proposed pathway for the formation of a- and x+1 ions.

4.7

Conclusion
CTD demonstrates an ability to distinguish isomeric forms of Asp and isoAsp in various

peptides on a benchtop instrument without chemical modification of the peptide. For CTD of
peptides containing Asp and isoAsp, the increased abundance of y- and z ions can be useful in
identifying isoAsp residues, whereas an increase in a ions correlates with Asp residues. Also, CTD
can generate unique cn+57 ions for isoAsp residues, in a similar fashion to ECD and ETD. For the
L- and D epimers of Asp and isoAsp, CTD demonstrates a degree of chiral discrimination that is
similar to or better than RDD. Comparison of relative peak abundances in epimer pairs of three
Asp-containing peptides and three isoAsp-containing peptides provided R values ranging from
2.6-70. Furthermore, a bn-45D/an-NH3 ion was found to be a reliable indicator for the D isomer of
Asp/isoAsp. Improved mass resolution would clarify the specific identity of the beneficial
fragment, which could then establish its relevance to L/D discrimination of Asp within peptides
containing all L amino acids. These findings show that CTD can provide reliable and structurally
meaningful fragments that are sensitive to conformational differences of peptides in the gas phase.
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5

Conclusions & Future Directions
Whereas CTD has demonstrated its effectiveness in certain applications, like the

characterization and isomer differentiation of complex oligosaccharides, 95,96 its potential
application to other areas has yet to be fully explored. Early experiments with peptides showed a
promising start92,93 and CTD is uncommon in its ability to fragment 1+ and 2+ precursor ions
though high energy radical processes. However, the CTD fragmentation efficiencies were typically
less than 10%, so signal-to-noise levels were not promising for on-line HPLC-CTD applications.
Our group therefore shifted focus to CTD of oligosaccharides, until Ryan Julian’s group at UC
Riverside demonstrated that RDD could effectively distinguish between isomeric amino acids. We
therefore revisited CTD of peptides with a view towards investigating isomeric amino acids. We
also looked into previously unexplored territory by applying CTD-MS to macrocyclic compounds.
Investigations into isomeric amino acids show that CTD is capable of differentiating Leu from
Ile and Asp from isoAsp without any chemical modifications to the peptide. Diagnostic secondary
ions, which are common in high-energy fragmentation techniques like HECD, are produced with
CTD and permit the differentiation of Leu and Ile. These d- and w ions are produced from 1+ and
2+ precursor ions, which is helpful because most small and medium peptides easily form low
charge states. Additionally, d- and w ions are observed with many other amino acids, so CTD could
be used to identify other isomeric amino acids, like norvaline and valine.174
Similar to ECD and ETD, CTD provides unique cn+57 ions for isoAsp residues, which can
differentiate Asp from isoAsp. In addition to the cn+57 ions for isoAsp, CTD also provides
differences in the relative abundance of other ions depending on whether the peptide contains
isoAsp- or Asp residues. For example, CTD spectra show an enhancement in z-ions for isoAsp
relative to Asp. Similar enhancements were also observed with ETD and MALDI-FRIPS of
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isoAsp/Asp residues in peptides. N-terminal backbone fragments at the Asp/isoAsp residue also
show a preference for Asp residues, so enhanced a-, b-, and c ions can also assist with
discriminating between Asp and isoAsp residues.
Chiral discrimination of L- and D epimers of Asp and isoAsp are also possible with CTD, and
CTD does not require any chemical modifications of the peptide, unlike RDD. Calculation of R
values shows CTD can achieve a degree of differentiation similar to, and in some cases higher
than, RDD, which is the state-of-the-art method to differentiate L- and D epimers of amino acids.
Analysis of macrocyclic compounds proved that CTD is capable of providing more numerous
structurally informative fragments than CID of the same compounds. Fragmentation of vitamin
B12 with CTD provided extensive coverage of the nucleotide loop region of the molecule. In
contrast, fragmentation with CID normally results in neutral losses of the major structural
components. For macrolides like Erythromycin, CID spectra are dominated by successive water
losses, but CTD demonstrates extensive coverage of the macrocyclic ring, similar to EID and
XUV-DPI. Fragmentation of a cyclic dimer of Nylon-6,6 proved challenging for CID, which
produced only successive monomer losses and some uninformative neutral losses. Activation of
the same ion with CTD provided a dominant 2+ CTnoD product ion. Isolation and fragmentation
by CID at the MS3 level of the CTnoD produced a rich product ion spectrum consistent with the
mechanism that CTD elicited ring-opening of the macrocycle and CID helped fragment the linear
intermediate. The combined use of CTD and CID provided unambiguous structural elucidation of
the macrocycle.
While this work demonstrates many promising applications of CTD, there is always room for
growth. Many of these studies, particularly those investigating macrocyclic compounds, faced
difficulties in spectral interpretation due to numerous isobaric ions. Therefore, coupling CTD to a
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high-resolution mass spectrometer (HRMS), such as an Orbitrap, would provide accurate mass
measurements and allow for greater confidence in assigning peak identities. The coupling of CTD
with a high-resolution instrument provides obvious advantages, especially for higher mass product
ions and symmetrical precursors, like oligosaccharides.
CTD demonstrates a high degree of chiral discrimination between epimers of aspartic acid, so
the analysis of mixtures would be possible with a suitable separation technique. Praneeth Mendis
in our group has already demonstrated the successful coupling of UHPLC with CTD-MS for the
analysis of complex mixtures of oligosaccharides,100 so UHPLC-CTD-MS would be a viable
method to separate peptides containing mixtures of L- and D epimers.229 Recent work has
demonstrated that ion mobility can be a good candidate for separating L- and D epimers of peptides
containing Asp residues.205 IMS-CTD-MS would provide fast separation and analysis of
enantiomers and could provide the necessary information for confident assignments of L- and D
epimers. Therefore, future work might also consider the coupling of an IMS cell to the front end
of a CTD-enabled mass spectrometer. Gabelica’s group at University of Bordeaux has already
configured an IMS cell to the same model of Bruker amaZon ion trap as ours, 236 so such a
modification is certainly possible. The ability to conduct CTD on IMS-separated precursors could
also help determine linkage patterns97 and localize areas of modification100 in mixtures of complex
oligosaccharides.237
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